committee,year,meeting_date,meeting_title,document_name,url,is_pdf,file_size
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","UPDATED PUBLIC PARTICIPATION INFORMATION: April 5, 2017: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm546576.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550010.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550011.pdf,True,18KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550012.pdf,True,46KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550014.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550015.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm550016.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",UPDATED MEETING TIME AND PUBLIC PARTICIPATION INFORMATION: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee,https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm536620.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545756.pdf,True,27KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545757.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm545759.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545758.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547228.pdf,True,38KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547232.pdf,True,10KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547233.pdf,True,36KB
Anesthetic and Analgesic Drug Products Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the March 13-14, 2017 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223402/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm547234.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","October 5, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm516000.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm522686.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523507.pdf,True,27KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523508.pdf,True,23KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523505.pdf,True,67KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524327.pdf,True,49KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524328.pdf,True,21KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524329.pdf,True,40KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm524330.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM527701.pdf,True,104KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM533421.pdf,True,900KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","September 15-16, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee, the Drug Safety and Risk Management Advisory Committee, and the Pediatric Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm486846.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm519721.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520393.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520394.pdf,True,23KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Pediatric Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520395.pdf,True,42KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520391.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522740.pdf,True,36KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522741.pdf,True,14KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522742.pdf,True,40KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm522743.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524875.pdf,True,82KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the September 15, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM531479.pdf,True,830KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the September 16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM531480.pdf,True,595KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","UPDATED Webnotice: August 4, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm509646.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514400.pdf,True,19KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514401.pdf,True,44KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm514372.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514399.pdf,True,68KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516578.pdf,True,23KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516580.pdf,True,13KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514396.pdf,True,33KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm516584.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM525207.pdf,True,40KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM527001.pdf,True,579KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","June 8, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491171.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505116.pdf,True,26KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505117.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm505120.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505118.pdf,True,68KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506642.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506644.pdf,True,13KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506646.pdf,True,27KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm506648.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM509606.pdf,True,42KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522092.pdf,True,554KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","June 7, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491156.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504837.pdf,True,26KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504838.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm504840.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504839.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506630.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506632.pdf,True,11KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506633.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm506635.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM512757.pdf,True,41KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516486.pdf,True,499KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","May 5, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm490754.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498780.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498781.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498782.pdf,True,67KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm498783.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501161.pdf,True,28KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501162.pdf,True,11KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501164.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm501165.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504263.pdf,True,42KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM507562.pdf,True,654KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","May 3-4, 2016: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm490628.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm497289.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498315.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498316.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498314.pdf,True,72KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501044.pdf,True,44KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501045.pdf,True,54KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501046.pdf,True,41KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the May 3-4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm501047.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the May 3-4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM509895.pdf,True,72KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the May 3, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522088.pdf,True,844KB
Anesthetic and Analgesic Drug Products Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the May 4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223620/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522089.pdf,True,876KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","November 6, 2015: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm462199.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM470713.pdf,True,27KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm470714.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM470715.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM472736.pdf,True,47KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM472737.pdf,True,11KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM472738.pdf,True,22KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm472739.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM477573.pdf,True,72KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-11-06,"November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the November 6, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478975.pdf,True,580KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","September 11, 2015: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm457905.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461635.pdf,True,26KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461636.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm461637.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461638.pdf,True,68KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462846.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462847.pdf,True,13KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462848.pdf,True,35KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm462849.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478973.pdf,True,48KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478974.pdf,True,695KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","September 10, 2015: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm457898.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461403.pdf,True,26KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461404.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm461406.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461405.pdf,True,68KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462832.pdf,True,28KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462833.pdf,True,13KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462835.pdf,True,35KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm462836.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM477907.pdf,True,73KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478972.pdf,True,714KB
Anesthetic and Analgesic Drug Products Advisory Committee,2015,,"CANCELLED: July 7-8, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","CANCELLED: July 7-8, 2015: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm448718.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2015,2015-03-18,"CANCELLED: March 18, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","CANCELLED: March 18, 2015 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223626/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm433359.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","November 24-25, 2014: Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm417300.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm422691.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM423925.pdf,True,39KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM423927.pdf,True,19KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM424416.pdf,True,50KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM423928.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM423929.pdf,True,72KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM425959.pdf,True,28KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM425960.pdf,True,14KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM425961.pdf,True,31KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm425962.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM429414.pdf,True,48KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the November 24, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM434384.pdf,True,802KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"November 24-25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the November 25, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM434385.pdf,True,376KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","June 11-12, 2014: Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm397059.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM400199.pdf,True,130KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM400200.pdf,True,24KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM400201.pdf,True,52KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM400202.pdf,True,28KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm400204.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM400203.pdf,True,71KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401648.pdf,True,97KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401652.pdf,True,18KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401654.pdf,True,40KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm401655.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM407429.pdf,True,68KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the June 11, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM410638.pdf,True,816KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,,"June 11-12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the June 12, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM410639.pdf,True,532KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","April 22, 2014: Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm390299.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM393774.pdf,True,41KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM393777.pdf,True,18KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM393778.pdf,True,40KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM393779.pdf,True,28KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm393781.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM393780.pdf,True,67KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM396865.pdf,True,12KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM396866.pdf,True,10KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM396867.pdf,True,15KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm396868.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM397335.pdf,True,39KB
Anesthetic and Analgesic Drug Products Advisory Committee,2014,2014-04-22,"April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the April 22, 2014 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM401161.pdf,True,618KB
Anesthetic and Analgesic Drug Products Advisory Committee,2013,2013-07-18,"July 18, 2013 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","CANCELLED July 18, 2013: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm351689.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2013,2013-07-17,"July 17, 2013 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","CANCELLED July 17, 2013: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223629/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm352826.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm327624.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM330676.pdf,True,38KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM330677.pdf,True,20KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM330678.pdf,True,35KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM330679.pdf,True,22KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm330681.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Webcast Information for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM330680.pdf,True,18KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM333210.pdf,True,15KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM333212.pdf,True,8KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM333215.pdf,True,12KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm333217.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM336475.pdf,True,41KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-12-07,"December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the December 7, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM339619.pdf,True,629KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm283966.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Agenda for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290270.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Questions for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290273.pdf,True,20KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Draft Meeting Roster for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290275.pdf,True,31KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Committee Roster for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM290276.pdf,True,14KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Briefing Information for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm290277.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Agenda for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM291583.pdf,True,29KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Questions for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM291584.pdf,True,10KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Final Meeting Roster for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM291585.pdf,True,46KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Slides for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm291586.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Minutes for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM304331.pdf,True,38KB
Anesthetic and Analgesic Drug Products Advisory Committee,2012,2012-02-09,"February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee","Transcript for the February 9, 2012 Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee",https://wayback.archive-it.org/7993/20170403223630/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM304332.pdf,True,434KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","March 10, 2011: Anesthetic and Life Support Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm238440.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm245745.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM246133.pdf,True,37KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM246134.pdf,True,25KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM246135.pdf,True,53KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Committee Roster for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM246136.pdf,True,23KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Webcast Information for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM246137.pdf,True,14KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM247643.pdf,True,31KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm247644.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM247783.pdf,True,32KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Meeting Roster for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM247784.pdf,True,35KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM251282.pdf,True,45KB
Anesthetic and Analgesic Drug Products Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the March 10, 2011 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223633/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM251283.pdf,True,621KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee CANCELLED","December 2, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement - CANCELLED",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm233301.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","October 21-22, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm227383.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm230102.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230103.pdf,True,101KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230104.pdf,True,87KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230105.pdf,True,102KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Committee Roster for the October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230106.pdf,True,76KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Committee Roster for the October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230107.pdf,True,70KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM233237.pdf,True,92KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM233238.pdf,True,74KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm233239.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236242.pdf,True,123KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the October 21, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236243.pdf,True,886KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the October 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236385.pdf,True,845KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","August 19, 2010: Anesthetic and Life Support  Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm218307.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm222692.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM222693.pdf,True,75KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM222695.pdf,True,65KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM222697.pdf,True,78KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Committee Roster for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM222698.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM225305.pdf,True,73KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM225306.pdf,True,56KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Meeting Roster for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM225307.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm225308.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM233737.pdf,True,693KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-08-19,"August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the August 19, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236241.pdf,True,78KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","July 2223, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214816.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm217507.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Waivers for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm218106.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219467.pdf,True,854KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219468.pdf,True,76KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219576.pdf,True,150KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220943.pdf,True,100KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220945.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Meeting Roster for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220946.pdf,True,150KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm220948.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the July 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224670.pdf,True,984KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the July 23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224671.pdf,True,854KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224672.pdf,True,230KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","April 22, 2010: Joint Meeting of the Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm205043.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm209140.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209148.pdf,True,323KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209149.pdf,True,289KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209150.pdf,True,305KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210847.pdf,True,93KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210848.pdf,True,83KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Meeting Roster for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210850.pdf,True,118KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm210851.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220274.pdf,True,96KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220275.pdf,True,910KB
Anesthetic and Analgesic Drug Products Advisory Committee,2010,2010-01-28,"January 28, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee - Cancelled","Meeting Cancelled - January 28, 2010: Anesthetic and Life Support Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223634/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm193292.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","September 24, 2009: Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm181088.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183201.pdf,True,55KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Meeting Roster for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183202.pdf,True,70KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm183203.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183206.pdf,True,54KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript (Open Session) for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187082.pdf,True,479KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187629.pdf,True,116KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248773.pdf,True,61KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248774.pdf,True,54KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm248775.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","September 23, 2009: Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm176521.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182976.pdf,True,59KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Meeting Roster for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182975.pdf,True,62KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",Anesthetic and Life Support Drugs Advisory Committee; 2009 Member Roster,https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182974.pdf,True,49KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm183033.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Questions for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182977.pdf,True,52KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm187486.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187490.pdf,True,471KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187630.pdf,True,66KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248760.pdf,True,61KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248763.pdf,True,44KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","June 29-30, 2009: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee: Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm143083.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","January 30, 2009: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm119906.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Agenda for the January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM119496.pdf,True,60KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Agenda for the January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM119506.pdf,True,61KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Meeting Roster for the January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM119522.pdf,True,71KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Draft Meeting Roster for the January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM119530.pdf,True,72KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committeee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm119990.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Final Questions for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM120015.pdf,True,48KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Written Statement for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm120018.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Slides for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm120036.htm,False,
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Transcript: Part 1 for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committeee",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM120095.pdf,True,532KB
Anesthetic and Analgesic Drug Products Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Anesthetic and Life Support Drugs Advisory Committee","Minutes for the January 30, 2009 Joint Meeting of the Anesthetic",https://wayback.archive-it.org/7993/20170403223635/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236238.pdf,True,71KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","November 4, 2016: Meeting of the Antimicrobial Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm518797.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Committee Roster for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM527687.pdf,True,28KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Briefing Information for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm527689.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Webcast Information for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM527688.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Agenda for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM528868.pdf,True,40KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Questions for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM528870.pdf,True,11KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Meeting Roster for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM528871.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Slides for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm528872.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Minutes for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM533973.pdf,True,58KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-11-04,"November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Transcript for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM536448.pdf,True,738KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","June 9, 2016: Meeting of the Antimicrobial Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm496386.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Committee Roster for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM505287.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Briefing Information for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm505289.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Webcast Information for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM505288.pdf,True,67KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Agenda for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM507567.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Questions for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM507570.pdf,True,10KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Final Meeting Roster for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM507572.pdf,True,25KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Slides for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm507574.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Minutes for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM510472.pdf,True,107KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2016,2016-06-09,"June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee","Transcript for the June 9, 2016 Meeting of the Antimicrobial Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223644/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM514109.pdf,True,663KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","November 5, 2015: Joint Meeting of the Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee) and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm465275.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Briefing Information for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm467380.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Antimicrobial Drugs Advisory Committee Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470451.pdf,True,28KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470452.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Webcast Information for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470453.pdf,True,68KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Final Agenda for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472650.pdf,True,25KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Final Questions for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472651.pdf,True,13KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Final Meeting Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472652.pdf,True,32KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Slides for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm472653.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Minutes for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM475246.pdf,True,82KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-11-05,"November 5, 2015 Meeting of the Antimicrobial Drugs Advisory Committee","Transcript for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM477657.pdf,True,934KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","January 22, 2015: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm424436.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM430744.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm430746.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Webcast Information for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM430745.pdf,True,66KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM431840.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM431841.pdf,True,84KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM431842.pdf,True,92KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm431843.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM440390.pdf,True,556KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2015,2015-01-22,"January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the January 22, 2015 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223645/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM440404.pdf,True,85KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","December 5, 2014: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm422477.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425453.pdf,True,59KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425454.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425455.pdf,True,35KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425456.pdf,True,25KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm425457.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426690.pdf,True,24KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426691.pdf,True,14KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426693.pdf,True,43KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (AIDAC)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm426694.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM432232.pdf,True,62KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-05,"December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the December 5, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM432233.pdf,True,609KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","December 4, 2014: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm420134.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm423871.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425291.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425293.pdf,True,23KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425294.pdf,True,63KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM425295.pdf,True,25KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426652.pdf,True,23KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426653.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426655.pdf,True,43KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm426656.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM432231.pdf,True,78KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-12-04,"December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the December 4, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM438264.pdf,True,763KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","March 31, 2014: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm385727.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390782.pdf,True,52KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390783.pdf,True,17KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390784.pdf,True,17KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390785.pdf,True,81KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390786.pdf,True,31KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm390788.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Webcast Information for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM390787.pdf,True,68KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM392547.pdf,True,39KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM392548.pdf,True,10KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM392550.pdf,True,11KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM392551.pdf,True,89KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm392555.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM396637.pdf,True,51KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM400337.pdf,True,384KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2014,2014-03-31,"March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the March 31, 2014 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223646/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM400338.pdf,True,361KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","October 18, 2013: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm364576.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371068.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371069.pdf,True,31KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371070.pdf,True,39KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371071.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm371073.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Webcast Information for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371072.pdf,True,17KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM383470.pdf,True,9KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM383471.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM383472.pdf,True,11KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm383473.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM389213.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-18,"October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the October 18, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM389215.pdf,True,1.2MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","October 17, 2013: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm364149.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm370490.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371032.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371033.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371034.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371035.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Webcast Information for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371036.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM374219.pdf,True,44KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM374220.pdf,True,31KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM374221.pdf,True,33KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm374222.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM397334.pdf,True,1.8MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2013,2013-10-17,"October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the October 17, 2013 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223650/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM419252.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","November 29, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm320230.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329471.pdf,True,35KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329472.pdf,True,14KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329473.pdf,True,102KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329474.pdf,True,97KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm329476.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332964.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332965.pdf,True,16KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332966.pdf,True,94KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm332967.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM340464.pdf,True,185KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-29,"November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the November 29, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM340465.pdf,True,1.6MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","November 28, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm321011.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329251.pdf,True,128KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329252.pdf,True,75KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329254.pdf,True,148KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329256.pdf,True,97KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm329257.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332956.pdf,True,30KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332957.pdf,True,76KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM332959.pdf,True,101KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm332960.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM337695.pdf,True,200KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-28,"November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the November 28, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM337696.pdf,True,1.8MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","November 2, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm319013.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM326179.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM326180.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM326181.pdf,True,40KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM326182.pdf,True,23KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm326183.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329759.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329760.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM329762.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm329764.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM334800.pdf,True,46KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-11-02,"November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the November 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM341045.pdf,True,1.4MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","September 5, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm311239.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM317651.pdf,True,94KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM317656.pdf,True,77KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM317662.pdf,True,104KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM317664.pdf,True,97KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Webcast Information for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM317666.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm317668.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM318768.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM318770.pdf,True,74KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM318771.pdf,True,137KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm318773.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM330604.pdf,True,160KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-09-05,"September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the September 5, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM330606.pdf,True,1.1MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","April 3-4, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm295163.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297871.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297953.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297955.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297956.pdf,True,35KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm297174.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299675.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299677.pdf,True,12KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299680.pdf,True,21KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305319.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305322.pdf,True,222KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297867.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297869.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee(PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297870.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm297863.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299676.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299679.pdf,True,12KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299681.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305320.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305323.pdf,True,248KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the April 3, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm299682.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM298153.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM298149.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM298150.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM298152.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm298154.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299766.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299767.pdf,True,12KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299768.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm299770.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305327.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,,"April 3-4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 4, 2012 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM305329.pdf,True,175KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","April 2, 2012: Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm293595.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297755.pdf,True,50KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297756.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297757.pdf,True,64KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Anti-Infective Drugs Advisory Committee Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297758.pdf,True,18KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297759.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm297760.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299206.pdf,True,35KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299207.pdf,True,13KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299208.pdf,True,40KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm299209.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304651.pdf,True,23KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2012,2012-04-02,"April 2, 2012 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223651/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304653.pdf,True,624KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","November 4, 2011 Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273363.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm275819.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277912.pdf,True,41KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277913.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277914.pdf,True,45KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277915.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM281969.pdf,True,32KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM281971.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm281973.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM285979.pdf,True,629KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-04,"November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the November 4, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304259.pdf,True,21KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","November 3, 2011 Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273354.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm275821.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277908.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277909.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277910.pdf,True,51KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM277911.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM281674.pdf,True,33KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM281675.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM281676.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm281677.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM285980.pdf,True,759KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-11-03,"November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the November 3, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304258.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","April 5, 2011 Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm242297.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM249346.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM249347.pdf,True,24KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM249348.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Committee Roster for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM249349.pdf,True,19KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm249350.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM251446.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM251448.pdf,True,14KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM251449.pdf,True,38KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm251451.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM254644.pdf,True,91KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2011,2011-04-05,"April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 5, 2011 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM254645.pdf,True,442KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","September 7, 2010: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm218190.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm224653.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM224654.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM224655.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM224851.pdf,True,44KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM225749.pdf,True,74KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM225751.pdf,True,32KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm225752.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM230379.pdf,True,104KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM230380.pdf,True,670KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-09-07,"September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the September 7, 2010 Meeting of the Anti-Infective Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM230381.pdf,True,299KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","April 29, 2010: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm208077.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm209837.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM209838.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM209839.pdf,True,27KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Meeting Roster for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM209927.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM212665.pdf,True,31KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM212667.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM212668.pdf,True,28KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm212669.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM215063.pdf,True,33KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2010,2010-04-29,"April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223702/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM215064.pdf,True,579KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","December 10, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm187928.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Materials for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm192913.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193018.pdf,True,52KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193019.pdf,True,48KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193020.pdf,True,68KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM197005.pdf,True,53KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM197006.pdf,True,11KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM197007.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm197008.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM196565.pdf,True,464KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-10,"December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the December 10, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM202195.pdf,True,23KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","December 9, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm187911.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Materials for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm190755.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193147.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193148.pdf,True,67KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM193149.pdf,True,37KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM195616.pdf,True,28KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM195617.pdf,True,72KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM195618.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm195619.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM196564.pdf,True,713KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-12-09,"December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the December 9, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM202194.pdf,True,88KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","October 27, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm183754.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Waivers for Conflicts of Interest for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm185858.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Materials for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm187299.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187292.pdf,True,21KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187293.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187295.pdf,True,45KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188444.pdf,True,20KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188445.pdf,True,15KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188446.pdf,True,29KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Committee Roster for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188447.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm188488.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM191757.pdf,True,525KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-27,"October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the October 27, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM196436.pdf,True,81KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","October 26, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm184291.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Materials for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm185669.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Agenda for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187284.pdf,True,22KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Draft Questions for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187285.pdf,True,30KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM187287.pdf,True,37KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Agenda for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188399.pdf,True,17KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Questions for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188400.pdf,True,28KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Meeting Roster for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188401.pdf,True,26KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Final Committee Roster for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188402.pdf,True,34KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm188440.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM191756.pdf,True,447KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-10-26,"October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the October 26, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM196435.pdf,True,64KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","June 3, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm126290.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM161855.pdf,True,36KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm161856.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm166994.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM188373.pdf,True,1.6MB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-03,"June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the June 3, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM183845.pdf,True,72KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","June 2, 2009: Anti-Infective Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm125552.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Meeting Roster for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM161842.pdf,True,35KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Briefing Information for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm161844.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Slides for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm166971.htm,False,
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM176366.pdf,True,561KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2009,2009-06-02,"June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee","Minutes for the June 2, 2009 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223703/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM183844.pdf,True,60KB
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee),2008,2008-12-03,"December 3, 2008 Meeting of the Anti-Infective Drugs Advisory Committee","Transcript for the December 3, 2008 Meeting of the Anti-Infective Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223708/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM225608.pdf,True,6MB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","July 13, 2016: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm506330.htm,False,
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Committee Roster for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510490.pdf,True,26KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Webcast Information for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510491.pdf,True,71KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Briefing Information for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm510492.htm,False,
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Slides for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm513077.htm,False,
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Final Agenda for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM513099.pdf,True,34KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Final Meeting Roster for the July 13, 2016 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM513101.pdf,True,32KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Final Questions for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM513104.pdf,True,18KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Minutes for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM518366.pdf,True,47KB
Arthritis Advisory Committee,2016,2016-07-13,"July 13, 2016 Meeting of the Arthritis Advisory Committee","Transcript for the July 13, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM518367.pdf,True,795KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","UPDATED INFORMATION: July 12, 2016: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm506845.htm,False,
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Committee Roster for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510290.pdf,True,26KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Webcast Information for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510291.pdf,True,66KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Briefing Information for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm510292.htm,False,
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Final Agenda for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM511893.pdf,True,27KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Final Questions for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM511894.pdf,True,19KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Final Meeting Roster for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM511895.pdf,True,16KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Slides for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm511896.htm,False,
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Minutes for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM520027.pdf,True,84KB
Arthritis Advisory Committee,2016,2016-07-12,"July 12, 2016 Meeting of the Arthritis Advisory Committee","Transcript for the July 12, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM520028.pdf,True,959KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","UPDATED PUBLIC PARTICIPATION INFORMATION: February 9, 2016: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm481969.htm,False,
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Committee Roster for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM484856.pdf,True,27KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Briefing Information for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm484858.htm,False,
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Webcast Information for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM485526.pdf,True,81KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Final Agenda for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM486165.pdf,True,31KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Final Questions for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM486166.pdf,True,15KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Final Meeting Roster for the February 9, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM486169.pdf,True,31KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Slides for the February 09, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm486170.htm,False,
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Transcript for the February 09, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM490414.pdf,True,902KB
Arthritis Advisory Committee,2016,2016-02-09,"February 9, 2016 Meeting of the Arthritis Advisory Committee","Minutes for the February 09, 2016 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223721/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM497990.pdf,True,51KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","October 23, 2015: Meeting of the Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm459034.htm,False,
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Draft Agenda for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM467932.pdf,True,399KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Draft Questions for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM467933.pdf,True,395KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Draft Meeting Roster for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM467935.pdf,True,399KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Committee Roster for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM467936.pdf,True,14KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Briefing Information for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm467938.htm,False,
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Webcast Information for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM467937.pdf,True,67KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Final Agenda for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM470232.pdf,True,11KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Final Questions for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM470233.pdf,True,11KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Final Meeting Roster for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM470234.pdf,True,11KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Slides for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm470235.htm,False,
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Minutes for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM475241.pdf,True,26KB
Arthritis Advisory Committee,2015,2015-10-23,"October 23, 2015 Meeting of the Arthritis Advisory Committee","Transcript for the October 23, 2015 Meeting of the Arthritis Advisory Committee (AAC)",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM480520.pdf,True,590KB
Arthritis Advisory Committee,2015,2015-03-17,"March 17, 2015 Meeting of the Arthritis Advisory Committee","POSTPONED: March 17, 2015: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223722/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm433919.htm,False,
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","February 10-11, 2014: Joint Meeting of the Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee  Meeting Announcement",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380871.htm,False,
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Briefing Information for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm383178.htm,False,
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Draft Agenda for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384895.pdf,True,104KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Draft Questions for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384896.pdf,True,20KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Draft Meeting Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384897.pdf,True,66KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Arthritis Advisory Committee Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384898.pdf,True,28KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384899.pdf,True,57KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Webcast Information for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM389285.pdf,True,72KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Final Agenda for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386425.pdf,True,67KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Final Questions for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386427.pdf,True,17KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Final Meeting Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386429.pdf,True,43KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Slides for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm386430.htm,False,
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Minutes for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM395527.pdf,True,86KB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Transcript for the February 10, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM398863.pdf,True,1.8MB
Arthritis Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Arthritis Advisory Committee","Transcript for the February 11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223723/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM398864.pdf,True,2.7MB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","July 23, 2013: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm355358.htm,False,
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361557.pdf,True,42KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361558.pdf,True,20KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361559.pdf,True,20KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361560.pdf,True,53KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the July 23, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm361562.htm,False,
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361561.pdf,True,18KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366512.pdf,True,27KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366513.pdf,True,17KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366514.pdf,True,14KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366515.pdf,True,39KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Slides for the July 23, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm366516.htm,False,
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the July 23, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM367286.pdf,True,51KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM370228.pdf,True,385KB
Arthritis Advisory Committee,2013,2013-07-23,"July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the July 23, 2013 Meeting of the Arthritis Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM370229.pdf,True,440KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","July 22, 2013: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm354580.htm,False,
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361338.pdf,True,29KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361339.pdf,True,20KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361556.pdf,True,40KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361340.pdf,True,27KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the July 22, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm361342.htm,False,
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM361341.pdf,True,18KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366480.pdf,True,20KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366481.pdf,True,14KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM366483.pdf,True,36KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Slides for the July 22, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm366485.htm,False,
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the July 22, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM367285.pdf,True,29KB
Arthritis Advisory Committee,2013,2013-07-22,"July 22, 2013 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the July 22, 2013 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223725/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM370227.pdf,True,705KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","December 20, 2012: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm,False,
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM332504.pdf,True,29KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM332505.pdf,True,17KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM332507.pdf,True,32KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM332508.pdf,True,13KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm332512.htm,False,
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM332510.pdf,True,29KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM334423.pdf,True,25KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM334424.pdf,True,11KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM334425.pdf,True,32KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Slides for the December 20, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm334427.htm,False,
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the December 20, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM345463.pdf,True,696KB
Arthritis Advisory Committee,2012,2012-12-20,"December 20, 2012 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the December 20, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM347288.pdf,True,29KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","May 9, 2012: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm295556.htm,False,
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Waivers for Conflicts of Interest for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm301426.htm,False,
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302951.pdf,True,40KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302952.pdf,True,22KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302953.pdf,True,50KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302954.pdf,True,27KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302955.pdf,True,29KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm302956.htm,False,
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304195.pdf,True,27KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304196.pdf,True,14KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304197.pdf,True,36KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Slides for the May 9, 2012 Meeting of the Arthritis Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm304198.htm,False,
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM313315.pdf,True,44KB
Arthritis Advisory Committee,2012,2012-05-09,"May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the May 9, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM313316.pdf,True,1.4MB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","May 8, 2012: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm295155.htm,False,
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302875.pdf,True,40KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302876.pdf,True,21KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302877.pdf,True,35KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302878.pdf,True,27KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM302880.pdf,True,30KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm302881.htm,False,
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304051.pdf,True,27KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304054.pdf,True,13KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM304055.pdf,True,27KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Slides for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm304056.htm,False,
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM313312.pdf,True,42KB
Arthritis Advisory Committee,2012,2012-05-08,"May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the May 8, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM313314.pdf,True,1.6MB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","March 12, 2012: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm286556.htm,False,
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295196.pdf,True,28KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295197.pdf,True,31KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295198.pdf,True,84KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295199.pdf,True,23KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Webcast Information for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295200.pdf,True,30KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm295201.htm,False,
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM301250.pdf,True,26KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM301251.pdf,True,17KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM301252.pdf,True,57KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Slides for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm301253.htm,False,
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM307879.pdf,True,50KB
Arthritis Advisory Committee,2012,2012-03-12,"March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the March 12, 2012 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223728/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM307880.pdf,True,664KB
Arthritis Advisory Committee,2011,2011-09-13,"September 13, 2011 Meeting of the Arthritis Drugs Advisory Committee","POSTPONED September 13, 2011: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm263496.htm,False,
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","June 21, 2011: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm256278.htm,False,
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM259592.pdf,True,38KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM259593.pdf,True,21KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM259594.pdf,True,36KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM259616.pdf,True,19KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm259595.htm,False,
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM262997.pdf,True,36KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM262998.pdf,True,19KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM262999.pdf,True,25KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Slides for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm263000.htm,False,
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM267388.pdf,True,50KB
Arthritis Advisory Committee,2011,2011-06-21,"June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the June 21, 2011 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223731/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM267391.pdf,True,649KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","November 16, 2010: Arthritis Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm226091.htm,False,
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM233574.pdf,True,53KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM233575.pdf,True,45KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM233576.pdf,True,48KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM233577.pdf,True,41KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm233578.htm,False,
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM241195.pdf,True,46KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM241196.pdf,True,40KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM241197.pdf,True,48KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM241198.pdf,True,806KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM241199.pdf,True,59KB
Arthritis Advisory Committee,2010,2010-11-16,"November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee","Slides for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm241200.htm,False,
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","August 20, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm217265.htm,False,
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222883.pdf,True,45KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Questions for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222884.pdf,True,44KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222885.pdf,True,62KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm222886.htm,False,
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223954.pdf,True,43KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223955.pdf,True,38KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223956.pdf,True,49KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Slides for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm223957.htm,False,
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM225445.pdf,True,490KB
Arthritis Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM227134.pdf,True,66KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","May 12, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm203426.htm,False,
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM211394.pdf,True,45KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Draft Meeting Roster for the May 12, 2010 Joint Meeting of the Arthritis Advisory Commitee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM211396.pdf,True,59KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm211459.htm,False,
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212675.pdf,True,41KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212676.pdf,True,40KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212677.pdf,True,38KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Slides for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm212678.htm,False,
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM214828.pdf,True,57KB
Arthritis Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223733/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM214829.pdf,True,757KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","September 16, 2009: Arthritis Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm174629.htm,False,
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Draft Agenda for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM176365.pdf,True,75KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM186160.pdf,True,56KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM182008.pdf,True,42KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Meeting Roster for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM182011.pdf,True,53KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM186162.pdf,True,41KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Committee Roster for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM186163.pdf,True,43KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm182012.htm,False,
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM186161.pdf,True,57KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Slides for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm186164.htm,False,
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM186962.pdf,True,379KB
Arthritis Advisory Committee,2009,2009-09-16,"September 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the September 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM188219.pdf,True,53KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","June 16, 2009: Arthritis Drug Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm155149.htm,False,
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Agenda for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM167746.pdf,True,72KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Agenda for the June 16, 2009 Arthritis Drug Advisory Committee(DOC - 33KB)",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM165704.doc,False,
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Committee Roster for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM167781.pdf,True,41KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Meeting Roster for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM167786.pdf,True,43KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Committee Roster for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM165706.pdf,True,40KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Meeting Roster for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM165707.pdf,True,59KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Briefing Information for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm165710.htm,False,
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Final Questions for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM167748.pdf,True,57KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Slides for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm167771.htm,False,
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Minutes for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM172499.pdf,True,51KB
Arthritis Advisory Committee,2009,2009-06-16,"June 16, 2009 Meeting of the Arthritis Drugs Advisory Committee","Transcript for the June 16, 2009 Meeting of the Arthritis Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403223734/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM174953.pdf,True,555KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","December 6, 2016: Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm522253.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Briefing Information for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm530329.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Committee Roster for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM531430.pdf,True,24KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM533739.pdf,True,28KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Questions for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM533740.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM533741.pdf,True,34KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Slides for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm533743.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Minutes for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM545226.pdf,True,55KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-12-06,"December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Transcript for the December 6, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM545227.pdf,True,494KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","October 19, 2016: Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm507636.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Committee Roster for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM525326.pdf,True,24KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Briefing Information for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm525328.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Webcast Information for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM525327.pdf,True,67KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM526952.pdf,True,24KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Questions for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM526953.pdf,True,14KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM526954.pdf,True,26KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Slides for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm526955.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Transcript for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM538583.pdf,True,739KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2016,2016-10-19,"October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Minutes for the October 19, 2016 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)",https://wayback.archive-it.org/7993/20170403223743/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM539912.pdf,True,47KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-11-03,"November 3, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","CANCELLED: November 3, 2015: Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm459227.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","June 4, 2015: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm446094.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449084.pdf,True,17KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449085.pdf,True,25KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Briefing Information for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm449087.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Webcast Information for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449086.pdf,True,68KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452153.pdf,True,27KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Questions for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452154.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452155.pdf,True,33KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Minutes for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM457283.pdf,True,52KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Slides for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm452156.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2015,2015-06-04,"June 4, 2015 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Transcript for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223744/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM459503.pdf,True,990KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-12-18,"December 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","UPDATED: December 18, 2014: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm423311.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-12-18,"December 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Agenda (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM426973.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-12-18,"December 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Meeting Roster (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM426974.pdf,True,63KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-12-18,"December 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM428050.pdf,True,13KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-12-18,"December 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM428052.pdf,True,37KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","September 18, 2014: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm406131.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412532.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Agenda for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414587.pdf,True,30KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Questions for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414588.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Meeting Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414589.pdf,True,46KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414590.pdf,True,17KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414591.pdf,True,22KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Briefing Information for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm414592.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416553.pdf,True,13KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Questions for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416554.pdf,True,11KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416556.pdf,True,32KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Slides for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm416557.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Minutes for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424069.pdf,True,38KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-18,"September 18, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Transcript for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424070.pdf,True,623KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412316.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Briefing Information for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412535.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Agenda for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414405.pdf,True,38KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Questions for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414406.pdf,True,32KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Draft Meeting Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414407.pdf,True,49KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414408.pdf,True,17KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414409.pdf,True,22KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Agenda for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416457.pdf,True,15KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Questions for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416458.pdf,True,23KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Final Meeting Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416459.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Slides for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm416460.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Minutes for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM418144.pdf,True,52KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2014,2014-09-17,"September 17, 2014 Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee","Transcript for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223746/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424068.pdf,True,890KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","UPDATED AGENDA INFORMATION: April 18, 2013: Joint Meeting of the Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm343879.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348083.pdf,True,38KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348084.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348085.pdf,True,49KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the April 18, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348086.pdf,True,14KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348087.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm348089.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Webcast Information for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348088.pdf,True,27KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349084.pdf,True,23KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349085.pdf,True,12KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349087.pdf,True,30KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm349088.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM350415.pdf,True,36KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-04-18,"April 18, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM358027.pdf,True,1.7MB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","March 5, 2013: Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Meeting Announcement",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm335406.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341770.pdf,True,30KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341771.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341772.pdf,True,47KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the March 5, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341775.pdf,True,14KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341777.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm341778.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Webcast Information for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341774.pdf,True,27KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343743.pdf,True,20KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343745.pdf,True,12KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343746.pdf,True,26KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm343747.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM351017.pdf,True,29KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-05,"March 5, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM351018.pdf,True,705KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","March 4, 2013: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm334186.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341582.pdf,True,50KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341629.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341630.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341583.pdf,True,55KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341584.pdf,True,14KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm341586.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Webcast Information for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341585.pdf,True,27KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343152.pdf,True,21KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343153.pdf,True,9KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343155.pdf,True,13KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343156.pdf,True,23KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the March 4, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm343157.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the March 4, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM350729.pdf,True,44KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the March 4, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) (AM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM350730.pdf,True,411KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2013,2013-03-04,"March 4, 2013 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the March 4, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) (PM Session)",https://wayback.archive-it.org/7993/20170403223747/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM350731.pdf,True,428KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","April 5, 2012: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm291237.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298278.pdf,True,30KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298279.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298280.pdf,True,34KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298281.pdf,True,14KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Webcast Information for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM298282.pdf,True,13KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm298283.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM300103.pdf,True,20KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM300105.pdf,True,12KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM300106.pdf,True,23KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm300107.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM303955.pdf,True,29KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-04-05,"April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the April 5, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM303956.pdf,True,1.6MB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","January 20, 2012: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm279859.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM287917.pdf,True,24KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM287918.pdf,True,18KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM288007.pdf,True,42KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM287919.pdf,True,13KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Webcast Information for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM287920.pdf,True,12KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm287986.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM290155.pdf,True,21KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM290156.pdf,True,10KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM290157.pdf,True,24KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm290158.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM291316.pdf,True,200KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2012,2012-01-20,"January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the January 20, 2012 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223748/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM292006.pdf,True,608KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","December 9, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273238.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282623.pdf,True,47KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282625.pdf,True,73KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282626.pdf,True,62KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Advisory Committee for Reproductive Health Drugs Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282628.pdf,True,25KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282630.pdf,True,32KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm282631.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284815.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284816.pdf,True,58KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284817.pdf,True,31KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm284818.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM292010.pdf,True,82KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-09,"December 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM292011.pdf,True,685KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","December 8, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273236.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282784.pdf,True,47KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282455.pdf,True,37KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282785.pdf,True,58KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Advisory Committee for Reproductive Health Drugs Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282458.pdf,True,25KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282459.pdf,True,32KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm282460.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284775.pdf,True,19KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284776.pdf,True,17KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284777.pdf,True,26KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm284778.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM288721.pdf,True,762KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-12-08,"December 8, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM288722.pdf,True,39KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","September 9, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm262477.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270955.pdf,True,51KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271214.pdf,True,30KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270956.pdf,True,32KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270964.pdf,True,51KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm270957.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271902.pdf,True,21KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271903.pdf,True,17KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271904.pdf,True,21KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm271905.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM275810.pdf,True,781KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerlyAdvisory Committee for Reproductive Health Drugs (ACRHD))",2011,2011-09-09,"September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223750/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM278481.pdf,True,31KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","June 18, 2010: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm210886.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm215436.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215439.pdf,True,73KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215440.pdf,True,74KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215441.pdf,True,90KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Committee Roster for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215442.pdf,True,76KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217422.pdf,True,70KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217423.pdf,True,63KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217424.pdf,True,80KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm217425.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM248753.pdf,True,775KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-18,"June 18, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the June 18, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM248751.pdf,True,85KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","June 17, 2010: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm210859.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm215424.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Agenda for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215431.pdf,True,73KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Questions for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215432.pdf,True,271KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Draft Meeting Roster for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215433.pdf,True,89KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Committee Roster for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215434.pdf,True,76KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217413.pdf,True,71KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217414.pdf,True,65KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Final Meeting Roster for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM217415.pdf,True,78KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm217416.htm,False,
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM218560.pdf,True,727KB
"Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))",2010,2010-06-17,"June 17, 2010 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the June 17, 2010 Meeting of the Advisory Committee for Reproductive Health Drugs",https://wayback.archive-it.org/7993/20170403223753/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM248749.pdf,True,85KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","August 13, 2009: Reproductive Health Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm168578.htm,False,
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Final Agenda for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM176367.pdf,True,64KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Committee Roster for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM176368.pdf,True,42KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Meeting Roster for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM176370.pdf,True,51KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Briefing Information for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm176584.htm,False,
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Slides for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm179778.htm,False,
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Transcript for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM187083.pdf,True,571KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Minutes for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM249267.pdf,True,56KB
Reproductive Health Drugs Advisory Committee,2009,2009-08-13,"August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee","Final Questions for the August 13, 2009 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223754/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM249385.pdf,True,45KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","April 15, 2015: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm436187.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM442196.pdf,True,23KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm442198.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM442197.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM444328.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM444329.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM444330.pdf,True,11KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm444331.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM457035.pdf,True,57KB
Cardiovascular and Renal Drugs Advisory Committee,2015,2015-04-15,"April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the April 15, 2015 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223806/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM457036.pdf,True,681KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","October 30, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm415986.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM420701.pdf,True,23KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm420703.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM420702.pdf,True,67KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM421608.pdf,True,23KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM421609.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM421610.pdf,True,22KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm421611.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM457033.pdf,True,785KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-10-30,"October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the October 30, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM463565.pdf,True,47KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","September 10, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm405489.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM413058.pdf,True,24KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm413060.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM413059.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM416028.pdf,True,20KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM416029.pdf,True,15KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM416030.pdf,True,30KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm416031.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM435075.pdf,True,741KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-10,"September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the September 10, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM456600.pdf,True,51KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","September 9, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm406953.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM412880.pdf,True,24KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm412882.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM412881.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM415975.pdf,True,19KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM415976.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM415977.pdf,True,33KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm415979.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM435074.pdf,True,482KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-09-09,"September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the September 9, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM456601.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","March 27, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm388348.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM390440.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm390442.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM390441.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM392153.pdf,True,57KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM392154.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM392155.pdf,True,11KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm392157.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM404040.pdf,True,90KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-03-27,"March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the March 27, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM404041.pdf,True,576KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-13,"February 13, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","POSTPONED February 13, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380828.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","February 12, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm381112.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM385231.pdf,True,28KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm385233.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM385232.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386770.pdf,True,63KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386774.pdf,True,52KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386776.pdf,True,26KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm386777.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM389209.pdf,True,137KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-02-12,"February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the February 12, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396711.pdf,True,2.1MB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","January 16, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm378921.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381459.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm381461.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381460.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386277.pdf,True,34KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386278.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386279.pdf,True,25KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm386280.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396034.pdf,True,26KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-16,"January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the January 16, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396036.pdf,True,805KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","January 15, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm378918.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381324.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm381326.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381325.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386262.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386264.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM386265.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm386267.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396031.pdf,True,83KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-15,"January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the January 15, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396033.pdf,True,751KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","January 14, 2014: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm378904.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381151.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm381153.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM381152.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM382735.pdf,True,48KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM382739.pdf,True,98KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM382742.pdf,True,13KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm382743.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396029.pdf,True,105KB
Cardiovascular and Renal Drugs Advisory Committee,2014,2014-01-14,"January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the January 14, 2014 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223807/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM396030.pdf,True,915KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","August 6, 2013: Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm358886.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363707.pdf,True,107KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363536.pdf,True,39KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363537.pdf,True,49KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363538.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm363540.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363539.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364879.pdf,True,93KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364881.pdf,True,28KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364882.pdf,True,35KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm364883.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Recording for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364884.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM373522.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-06,"August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the August 6, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM398866.pdf,True,484KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","August 5, 2013: Meeting of the Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm357792.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363337.pdf,True,100KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363338.pdf,True,64KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363339.pdf,True,56KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363340.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm363342.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM363341.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364578.pdf,True,89KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364579.pdf,True,50KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM364580.pdf,True,39KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm364581.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM373520.pdf,True,124KB
Cardiovascular and Renal Drugs Advisory Committee,2013,2013-08-05,"August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the August 5, 2013 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223808/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM398865.pdf,True,1MB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-14,"September 14, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","CANCELLED September 14, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm313019.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","September 13, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm313273.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318859.pdf,True,68KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318861.pdf,True,24KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318862.pdf,True,25KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318863.pdf,True,28KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318864.pdf,True,15KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM318865.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm318866.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM320595.pdf,True,53KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM320625.pdf,True,15KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM320596.pdf,True,14KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM320597.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm320598.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM337172.pdf,True,79KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM345074.pdf,True,449KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-09-13,"September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM345075.pdf,True,393KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","May 23, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm299942.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM304750.pdf,True,52KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM304955.pdf,True,93KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM304751.pdf,True,41KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM304752.pdf,True,19KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM304753.pdf,True,26KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm304754.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM305916.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM305917.pdf,True,78KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM305918.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm305920.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM310093.pdf,True,89KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-05-23,"May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the May 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM313199.pdf,True,706KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-03-27,"CANCELLED March 27, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","CANCELLED March 27, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm293579.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","February 23, 2012: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm285414.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM292626.pdf,True,51KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM292627.pdf,True,51KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM292628.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM292629.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm292630.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM294072.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM294073.pdf,True,41KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM294074.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm294075.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM298452.pdf,True,30KB
Cardiovascular and Renal Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the February 23, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223810/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM298453.pdf,True,685KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","September 8, 2011: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm261963.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM270791.pdf,True,66KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM270792.pdf,True,153KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM270793.pdf,True,60KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM270794.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm270795.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM271996.pdf,True,55KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM271997.pdf,True,114KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM271998.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm271999.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM277588.pdf,True,784KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-09-08,"September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM278480.pdf,True,90KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","May 2, 2011: Joint Meeting of the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm250268.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252867.pdf,True,70KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252868.pdf,True,60KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252869.pdf,True,53KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252870.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252871.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252872.pdf,True,15KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm252873.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254384.pdf,True,53KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254385.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254387.pdf,True,37KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm254389.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM255248.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223812/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM256586.pdf,True,791KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","December 8, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm235222.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM235792.pdf,True,40KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM235793.pdf,True,35KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Committee Roster for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM235794.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236051.pdf,True,48KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Webcast Information for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM235795.pdf,True,14KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm235796.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM237000.pdf,True,40KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM237001.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM237002.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm237003.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM238530.pdf,True,384KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-12-08,"December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the December 8, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM241788.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","October 18, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm226531.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM229324.pdf,True,37KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM229475.pdf,True,58KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm229325.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM231856.pdf,True,40KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM231972.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM231974.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm231976.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM233461.pdf,True,1MB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-10-18,"October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the October 18, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236323.pdf,True,58KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm224194.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226005.pdf,True,25KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226006.pdf,True,122KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226007.pdf,True,41KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm226008.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226698.pdf,True,24KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226700.pdf,True,101KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226702.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm226703.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM233739.pdf,True,900KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-09-20,"September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236322.pdf,True,94KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","July 29, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm217266.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm220249.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220246.pdf,True,56KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220247.pdf,True,93KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220248.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221819.pdf,True,30KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221821.pdf,True,76KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221822.pdf,True,27KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm221823.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM223580.pdf,True,849KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-29,"July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the July 29, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM225329.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","July 28, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214252.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm220190.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220186.pdf,True,54KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220187.pdf,True,106KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM220189.pdf,True,37KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221379.pdf,True,38KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221380.pdf,True,86KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM221381.pdf,True,25KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm221382.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM223579.pdf,True,891KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-07-28,"July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the July 28, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM225328.pdf,True,51KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","March 1, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm197014.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Waivers for Conflicts of Interest for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm200304.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm201857.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM201856.pdf,True,32KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM202134.pdf,True,28KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM202135.pdf,True,45KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM203504.pdf,True,49KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM203506.pdf,True,18KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM203508.pdf,True,29KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm203511.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM207847.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-03-01,"March 1, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM209252.pdf,True,478KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","January 11, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm192659.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm196556.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196561.pdf,True,31KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196562.pdf,True,100KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196563.pdf,True,59KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM197971.pdf,True,44KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM197972.pdf,True,82KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Roster for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM197973.pdf,True,33KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm197978.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM199554.pdf,True,555KB
Cardiovascular and Renal Drugs Advisory Committee,2010,2010-01-11,"January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the January 11, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223814/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM208758.pdf,True,47KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","December 8, 2009: Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm186142.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm190843.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192844.pdf,True,62KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Meeting Roster for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192845.pdf,True,61KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196212.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196213.pdf,True,50KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196214.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm196216.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM197768.pdf,True,586KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236119.pdf,True,51KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","December 7, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm186125.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Waivers for Conflicts of Interest for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm191573.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm192708.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192709.pdf,True,55KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Meeting Roster for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192820.pdf,True,53KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM195968.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Questions for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM195969.pdf,True,39KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Meeting Roster for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM195970.pdf,True,40KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm195971.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196440.pdf,True,680KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-12-07,"December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Minutes for the December 7, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236120.pdf,True,54KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","July 29, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm164988.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM173519.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Meeting Roster for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM173520.pdf,True,39KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm173521.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Questions for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM176204.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm176205.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM181246.pdf,True,481KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-29,"July 29, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Summary Minutes for the July 29, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM184205.pdf,True,121KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","July 28, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm164601.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM173458.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Meeting Roster for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM173461.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm173463.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Questions for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM176201.pdf,True,52KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm176203.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM181245.pdf,True,609KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-07-28,"July 28, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Summary Minutes for the July 28, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM184204.pdf,True,52KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","March 19, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm128324.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Agenda for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM137009.pdf,True,42KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Roster for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM137011.pdf,True,46KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm138368.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Questions for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM143241.pdf,True,36KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm143643.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the March 19, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM143863.pdf,True,457KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-19,"March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Summary Minutes for the March 19, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM151671.pdf,True,52KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","March 18, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm128322.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM134970.pdf,True,53KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm134972.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Questions for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM136944.pdf,True,109KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm136947.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM151343.pdf,True,506KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-03-18,"March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Summary Minutes for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM151691.pdf,True,71KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","February 3, 2009: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm128321.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Agenda for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM129199.pdf,True,43KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Agenda for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM129201.pdf,True,48KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Draft Meeting Roster for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM129204.pdf,True,50KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Briefing Information for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm129208.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Slides for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm129152.htm,False,
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Final Minutes for the February 3, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM136140.pdf,True,54KB
Cardiovascular and Renal Drugs Advisory Committee,2009,2009-02-03,"February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee","Transcript for the February 3, 2009 Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223815/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM136141.pdf,True,556KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","July 19, 2016: Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm506094.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM511354.pdf,True,85KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) - Webcast Recording",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM513280.pdf,True,73KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm511356.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm513229.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM513247.pdf,True,38KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM513276.pdf,True,31KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM513277.pdf,True,18KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM520400.pdf,True,78KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2016,2016-07-19,"July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the July 19, 2016 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223827/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM520401.pdf,True,774KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","March 9, 2015: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm431500.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436599.pdf,True,19KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm436601.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Webcast Information for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436600.pdf,True,68KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM439344.pdf,True,35KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM439345.pdf,True,28KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM439346.pdf,True,45KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM439348.pdf,True,37KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm439349.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM446394.pdf,True,496KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM446396.pdf,True,532KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-03-09,"March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the March 9, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM446397.pdf,True,1.5MB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","February 24, 2015: Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee and Ophthalmic Devices Panel of the Medical Devices Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm432017.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Dermatologic and Ophthalmic Drugs Advisory Committee Roster for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM435017.pdf,True,19KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Ophthalmic Devices Panel Committee Roster for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM435018.pdf,True,17KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm435020.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Webcast Information for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM435019.pdf,True,72KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436465.pdf,True,23KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436466.pdf,True,71KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM436467.pdf,True,26KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm436469.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM450252.pdf,True,98KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2015,2015-02-24,"February 24, 2015 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee",https://wayback.archive-it.org/7993/20170403223828/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM450253.pdf,True,833KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","October 20, 2014: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm404910.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Agenda for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM419015.pdf,True,30KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM419016.pdf,True,49KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Meeting Roster for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM419017.pdf,True,29KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM419018.pdf,True,19KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm419020.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Webcast Information for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM419019.pdf,True,67KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM420455.pdf,True,28KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM420456.pdf,True,42KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM420458.pdf,True,17KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm420459.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM425465.pdf,True,65KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2014,2014-10-20,"October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the October 20, 2014 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC)",https://wayback.archive-it.org/7993/20170403223830/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM425466.pdf,True,678KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","July 26, 2012: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm308843.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Agenda for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313078.pdf,True,49KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313080.pdf,True,39KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313081.pdf,True,20KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Meeting Roster for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313082.pdf,True,56KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313083.pdf,True,28KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Webcast Information for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM313084.pdf,True,29KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm313085.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM314192.pdf,True,24KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM314193.pdf,True,33KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM315646.pdf,True,13KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM314195.pdf,True,19KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm314196.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM320122.pdf,True,72KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM321064.pdf,True,1.1MB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-07-26,"July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM321066.pdf,True,927KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","February 27, 2012: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm280521.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm291778.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Agenda for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM292917.pdf,True,18KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM292920.pdf,True,19KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Meeting Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM292921.pdf,True,29KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM292922.pdf,True,20KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM294515.pdf,True,22KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM294516.pdf,True,10KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM294517.pdf,True,32KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm294518.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM305318.pdf,True,1.1MB
Dermatologic and Ophthalmic Drugs Advisory Committee,2012,2012-02-27,"February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM306300.pdf,True,45KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","December 1, 2011: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm275806.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Agenda for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281362.pdf,True,76KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281363.pdf,True,46KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281364.pdf,True,47KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Meeting Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281366.pdf,True,52KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM281378.pdf,True,67KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Dermatologic and Ophthalmic Drugs Advisory Committee Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281367.pdf,True,26KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Webcast Information for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281370.pdf,True,12KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm281372.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285042.pdf,True,47KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285043.pdf,True,33KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285044.pdf,True,33KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285045.pdf,True,25KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm285046.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289346.pdf,True,41KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289347.pdf,True,391KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting   of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289348.pdf,True,323KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","June 17, 2011: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm256594.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Agenda for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM259137.pdf,True,33KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Questions for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM259138.pdf,True,12KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Draft Meeting Roster for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM259139.pdf,True,59KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Committee Roster for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM259140.pdf,True,26KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm259141.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Agenda for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM266818.pdf,True,27KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Questions for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM266819.pdf,True,13KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Final Meeting Roster for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM266820.pdf,True,28KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM266821.pdf,True,41KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM266822.pdf,True,428KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2011,2011-06-17,"June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for the June 17, 2011 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223832/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm266823.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2010,2010-06-28,"CANCELLED: June 28, 2010 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","CANCELLED June 28, 2010: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223834/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm211778.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm163761.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Agenda for the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM168679.pdf,True,59KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Meeting Roster for the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM168683.pdf,True,56KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Briefing Information for the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm168685.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Questions for the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM168694.pdf,True,46KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for Session 1 of the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM176270.pdf,True,237KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for Session 1 of the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm176273.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Transcript for Session 2 of the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM176281.pdf,True,890KB
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Slides for Session 2 of the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm176283.htm,False,
Dermatologic and Ophthalmic Drugs Advisory Committee,2009,2009-06-26,"June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee","Minutes for the June 26, 2009 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223835/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM187483.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED PUBLIC PARTICIPATION INFORMATION: April 5, 2017: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm546576.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550010.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550011.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550012.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550015.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM550014.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-05,"April 5, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the April 5, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm550016.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","April 4, 2017: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm544701.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549884.pdf,True,34KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549885.pdf,True,20KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549886.pdf,True,63KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549888.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549887.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm549889.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee",UPDATED MEETING TIME AND PUBLIC PARTICIPATION INFORMATION: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee,https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm536620.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545757.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545756.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm545759.htm,False,
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM545758.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547228.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547232.pdf,True,10KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the March 13-14, 2017 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM547233.pdf,True,36KB
Drug Safety and Risk Management Advisory Committee,2017,,"March 13-14, 2017 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the March 13-14, 2017 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223841/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm547234.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","October 5, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm516000.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm522686.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523508.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523507.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM523505.pdf,True,67KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524327.pdf,True,49KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524328.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524329.pdf,True,40KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm524330.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM527701.pdf,True,104KB
Drug Safety and Risk Management Advisory Committee,2016,2016-10-05,"October 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the October 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM533421.pdf,True,900KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","September 15-16, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee, the Drug Safety and Risk Management Advisory Committee, and the Pediatric Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm486846.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm519721.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520394.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520393.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Pediatric Advisory Committee Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520395.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM520391.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522740.pdf,True,36KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522741.pdf,True,14KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522742.pdf,True,40KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm522743.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 15-16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524875.pdf,True,82KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 15, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM531479.pdf,True,830KB
Drug Safety and Risk Management Advisory Committee,2016,,"September 15-16, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 16, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), the Drug Safety and Risk Management Advisory Committee (DSaRM), and the Pediatric Advisory Committee (PAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM531480.pdf,True,595KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","September 14, 2016: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm513811.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520100.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Psychopharmacologic Drugs Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520099.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm520102.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520101.pdf,True,69KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522575.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522576.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522578.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm522580.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM524402.pdf,True,83KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED Webnotice: August 4, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm509646.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514401.pdf,True,44KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514400.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm514372.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514399.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516578.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516580.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM514396.pdf,True,33KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm516584.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM525207.pdf,True,40KB
Drug Safety and Risk Management Advisory Committee,2016,2016-08-04,"August 4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the August 4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM527001.pdf,True,579KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","June 8, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491171.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505117.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505116.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm505120.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM505118.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506642.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506644.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506646.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm506648.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM509606.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-08,"June 8, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the June 8, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522092.pdf,True,554KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","June 7, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491156.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504838.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504837.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm504840.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504839.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506630.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506632.pdf,True,11KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM506633.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm506635.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM512757.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2016,2016-06-07,"June 7, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the June 7, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM516486.pdf,True,499KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","May 5, 2016: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm490754.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498781.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498780.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498782.pdf,True,67KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm498783.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501161.pdf,True,28KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501162.pdf,True,11KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501164.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm501165.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM504263.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2016,2016-05-05,"May 5, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the May 5, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM507562.pdf,True,654KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","May 3-4, 2016: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm490628.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm497289.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498316.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498315.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM498314.pdf,True,72KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501044.pdf,True,44KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501045.pdf,True,54KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the May 3-4, 2016 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM501046.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the May 3-4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm501047.htm,False,
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the May 3-4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM509895.pdf,True,72KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the May 3, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522088.pdf,True,844KB
Drug Safety and Risk Management Advisory Committee,2016,,"May 3-4, 2016 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the May 4, 2016 Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)",https://wayback.archive-it.org/7993/20170403223842/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM522089.pdf,True,876KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","December 10, 2015: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and the Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm469466.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Waiver for Conflicts of Interest for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm474207.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475972.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm475974.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475973.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477953.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477954.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477957.pdf,True,34KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm477958.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM482005.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM487401.pdf,True,694KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","November 5, 2015: Joint Meeting of the Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee) and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm465275.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm467380.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470452.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Antimicrobial Drugs Advisory Committee Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470451.pdf,True,28KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM470453.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472650.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472651.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM472652.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm472653.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM475246.pdf,True,82KB
Drug Safety and Risk Management Advisory Committee,2015,2015-11-05,"November 5, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the November 5, 2015 Joint Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM477657.pdf,True,934KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","September 11, 2015: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm457905.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461636.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461635.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm461637.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461638.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462846.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462847.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462848.pdf,True,35KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm462849.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478973.pdf,True,48KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-11,"September 11, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 11, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478974.pdf,True,695KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","September 10, 2015: Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm457898.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461404.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Anesthetic and Analgesic Drug Products Advisory Committee Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461403.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm461406.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM461405.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462832.pdf,True,28KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462833.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM462835.pdf,True,35KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm462836.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM477907.pdf,True,73KB
Drug Safety and Risk Management Advisory Committee,2015,2015-09-10,"September 10, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 10, 2015 Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM478972.pdf,True,714KB
Drug Safety and Risk Management Advisory Committee,2015,,"CANCELLED: July 7-8, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","CANCELLED: July 7-8, 2015: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm448718.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","June 4, 2015: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm446094.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449085.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449084.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm449087.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449086.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452153.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452154.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM452155.pdf,True,33KB
Drug Safety and Risk Management Advisory Committee,2015,2015-06-04,"June 4, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 4, 2015 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm452156.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","March 19, 2015: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm433812.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM438377.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Pulmonary-Allergy Drugs Advisory Committee Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM438376.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm438378.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440057.pdf,True,28KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440058.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440059.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm440061.htm,False,
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM443421.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223846/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM447787.pdf,True,866KB
Drug Safety and Risk Management Advisory Committee,2014,2014-12-18,"December 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED: December 18, 2014: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm423311.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-12-18,"December 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM428050.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2014,2014-12-18,"December 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster (Open Session) for the December 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM428052.pdf,True,37KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","November 18, 2014: Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm417986.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM423027.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm423029.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM423028.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM426183.pdf,True,39KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM426184.pdf,True,11KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM426185.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm426662.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM456780.pdf,True,37KB
Drug Safety and Risk Management Advisory Committee,2014,2014-11-18,"November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the November 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM456781.pdf,True,539KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","October 16, 2014: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and  the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm394876.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418702.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Psychopharmacologic Drugs Advisory Committee Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418701.pdf,True,20KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm418704.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418703.pdf,True,69KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420252.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420253.pdf,True,10KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420255.pdf,True,49KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm420257.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM433774.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM434007.pdf,True,761KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","September 18, 2014: Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm406131.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Waivers for Conflicts of Interest for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412532.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414591.pdf,True,22KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414590.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm414592.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416553.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416554.pdf,True,11KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416556.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm416557.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424069.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-18,"September 18, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 18, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424070.pdf,True,623KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Waivers for Conflicts of Interest for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412316.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm412535.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414409.pdf,True,22KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Bone, Reproductive and Urologic Drugs Advisory Committee Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM414408.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416457.pdf,True,15KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416458.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM416459.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm416460.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM418144.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2014,2014-09-17,"September 17, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 17, 2014 Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee Meeting",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM424068.pdf,True,890KB
Drug Safety and Risk Management Advisory Committee,2014,2014-10-16,"October 16, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","October 16, 2014: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and  the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm394876.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","February 10-11, 2014: Joint Meeting of the Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee  Meeting Announcement",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380871.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm383178.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384899.pdf,True,57KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Arthritis Advisory Committee Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM384898.pdf,True,28KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM389285.pdf,True,72KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386425.pdf,True,67KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386427.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM386429.pdf,True,43KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm386430.htm,False,
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the February 10-11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM395527.pdf,True,86KB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the February 10, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM398863.pdf,True,1.8MB
Drug Safety and Risk Management Advisory Committee,2014,,"February 10-11, 2014 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the February 11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223847/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM398864.pdf,True,2.7MB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED AGENDA INFORMATION: December 9, 2013: Joint Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM) Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371059.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377607.pdf,True,70KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377608.pdf,True,72KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377609.pdf,True,54KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377612.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Gastrointestinal Drugs Advisory Committee Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377610.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm377615.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377614.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378741.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378745.pdf,True,64KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378747.pdf,True,31KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm378750.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM384619.pdf,True,145KB
Drug Safety and Risk Management Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM390834.pdf,True,680KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","July 10, 2013: Meeting of the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm353763.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM359748.pdf,True,65KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM359749.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM359750.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM359751.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm359753.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM359752.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM361253.pdf,True,75KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM361273.pdf,True,13KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM361272.pdf,True,48KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm361275.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM366931.pdf,True,748KB
Drug Safety and Risk Management Advisory Committee,2013,2013-07-10,"July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the July 10, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM369994.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","June 5-6, 2013: Joint Meeting of the Endocrinilogic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm348146.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354850.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354851.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354894.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354854.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354853.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm354858.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354857.pdf,True,16KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356304.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356305.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356306.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm356307.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369180.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the June 5, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369182.pdf,True,899KB
Drug Safety and Risk Management Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the June 6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369183.pdf,True,787KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED AGENDA INFORMATION: April 18, 2013: Joint Meeting of the Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm343879.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348083.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348084.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348085.pdf,True,49KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348087.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the April 18, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348086.pdf,True,14KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm348089.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM348088.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349084.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349085.pdf,True,12KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM349087.pdf,True,30KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm349088.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM350415.pdf,True,36KB
Drug Safety and Risk Management Advisory Committee,2013,2013-04-18,"April 18, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the April 18, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM358027.pdf,True,1.7MB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","March 5, 2013: Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm335406.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341770.pdf,True,30KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341771.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341772.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341777.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the March 5, 2013 Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341775.pdf,True,14KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm341778.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM341774.pdf,True,27KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343743.pdf,True,20KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343745.pdf,True,12KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM343746.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm343747.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM351017.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2013,2013-03-05,"March 5, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the March 5, 2013 Joint Meeting of the Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM351018.pdf,True,705KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","January 24-25, 2013: Meeting of the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm332857.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm334275.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM336292.pdf,True,103KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM336294.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM336323.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM336295.pdf,True,20KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM336296.pdf,True,16KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM337144.pdf,True,69KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM337145.pdf,True,10KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM337146.pdf,True,34KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm337147.htm,False,
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM344674.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the January 24, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM346941.pdf,True,960KB
Drug Safety and Risk Management Advisory Committee,2013,,"January 24-25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the January 25, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223850/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM346942.pdf,True,762KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","UPDATED PUBLIC PARTICIPATION INFORMATION: December 12-13, 2012: Meeting of the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm325571.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm331162.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331417.pdf,True,76KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331418.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331769.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331644.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331421.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333329.pdf,True,60KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333333.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333336.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm333337.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM343814.pdf,True,24KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 12, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM343816.pdf,True,1.9MB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm331165.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331603.pdf,True,57KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331604.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331770.pdf,True,43KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331645.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM331605.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333364.pdf,True,42KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333366.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM333367.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm333368.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM343936.pdf,True,23KB
Drug Safety and Risk Management Advisory Committee,2012,,"December 12-13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 13, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM350496.pdf,True,1.6MB
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","POSTPONED: October 29-30, 2012: Meeting of the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm307371.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm325706.htm,False,
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM325701.pdf,True,116KB
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM325702.pdf,True,18KB
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM325703.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM325704.pdf,True,29KB
Drug Safety and Risk Management Advisory Committee,2012,,"October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the October 29-30, 2012 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223854/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM325705.pdf,True,14KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","December 9, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273238.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282623.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282625.pdf,True,73KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282626.pdf,True,62KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Advisory Committee for Reproductive Health Drugs Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282628.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282630.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm282631.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284815.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284816.pdf,True,58KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284817.pdf,True,31KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm284818.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM292010.pdf,True,82KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-09,"December 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM292011.pdf,True,685KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","December 8, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273236.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282784.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282455.pdf,True,37KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282785.pdf,True,58KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Advisory Committee for Reproductive Health Drugs Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282458.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM282459.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm282460.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284775.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284776.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM284777.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm284778.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM288721.pdf,True,762KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-08,"December 8, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM288722.pdf,True,39KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","December 1, 2011: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm275806.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281362.pdf,True,76KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281363.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281364.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281366.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM281378.pdf,True,67KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Dermatologic and Ophthalmic Drugs Advisory Committee Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281367.pdf,True,26KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM281370.pdf,True,12KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm281372.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285042.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285043.pdf,True,33KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285044.pdf,True,33KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM285045.pdf,True,25KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/ucm285046.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289346.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289347.pdf,True,391KB
Drug Safety and Risk Management Advisory Committee,2011,2011-12-01,"December 1, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 1, 2011 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM289348.pdf,True,323KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","September 9, 2011: Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm262477.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270955.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270956.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the September 9, 2011 Meeting of the Reproductive Health Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271214.pdf,True,30KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM270964.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm270957.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271902.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271903.pdf,True,17KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM271904.pdf,True,21KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/ucm271905.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM275810.pdf,True,781KB
Drug Safety and Risk Management Advisory Committee,2011,2011-09-09,"September 9, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 9, 2011 Joint Meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM278481.pdf,True,31KB
Drug Safety and Risk Management Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","July 20, 2011: Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm260716.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263172.pdf,True,20KB
Drug Safety and Risk Management Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263174.pdf,True,39KB
Drug Safety and Risk Management Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263173.pdf,True,19KB
Drug Safety and Risk Management Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM272026.pdf,True,87KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","May 2, 2011: Joint Meeting of the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm250268.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252867.pdf,True,70KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252868.pdf,True,60KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252869.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the May 2, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252870.pdf,True,31KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252871.pdf,True,32KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Webcast Information for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM252872.pdf,True,15KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm252873.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254384.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254385.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM254387.pdf,True,37KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm254389.htm,False,
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM255248.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2011,2011-05-02,"May 2, 2011 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the May 2, 2011 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223855/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM256586.pdf,True,791KB
Drug Safety and Risk Management Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","December 2, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement - CANCELLED",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm233301.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","November 3, 2010: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm225864.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231772.pdf,True,77KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231773.pdf,True,277KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231774.pdf,True,58KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm231775.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM232203.pdf,True,98KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233351.pdf,True,73KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233404.pdf,True,71KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233352.pdf,True,89KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm233353.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM243258.pdf,True,53KB
Drug Safety and Risk Management Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM284384.pdf,True,560KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","October 21-22, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm227383.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm230102.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230103.pdf,True,101KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230104.pdf,True,87KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230105.pdf,True,102KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Committee Roster for the October 21-22, 2010 Meeting of the Anesthetic and Life Support Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230106.pdf,True,76KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Committee Roster for the October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM230107.pdf,True,70KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM233237.pdf,True,92KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM233238.pdf,True,74KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm233239.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the October 21-22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236242.pdf,True,123KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the October 21, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236243.pdf,True,886KB
Drug Safety and Risk Management Advisory Committee,2010,,"October 21-22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the October 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236385.pdf,True,845KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","September 14, 2010: Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm211003.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm224445.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM225391.pdf,True,97KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM225392.pdf,True,55KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM225393.pdf,True,107KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM226617.pdf,True,111KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM226618.pdf,True,34KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM226619.pdf,True,94KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm226620.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM228267.pdf,True,954KB
Drug Safety and Risk Management Advisory Committee,2010,2010-09-14,"September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM235010.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","August 20, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm217265.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222883.pdf,True,45KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222884.pdf,True,44KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM222885.pdf,True,62KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm222886.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223954.pdf,True,43KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223955.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM223956.pdf,True,49KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm223957.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM225445.pdf,True,490KB
Drug Safety and Risk Management Advisory Committee,2010,2010-08-20,"August 20, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the August 20, 2010 Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM227134.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","July 2223, 2010: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214816.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm217507.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Waivers for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm218106.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219467.pdf,True,854KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219468.pdf,True,76KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM219576.pdf,True,150KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220943.pdf,True,100KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220945.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220946.pdf,True,150KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm220948.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224670.pdf,True,984KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224671.pdf,True,854KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 22-23, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the July 22-23, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM224672.pdf,True,230KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","July 1314, 2010: Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214612.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218478.pdf,True,128KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218479.pdf,True,285KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Pre-Meeting Posting of Slides for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm218481.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm218491.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218527.pdf,True,135KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222622.pdf,True,115KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222625.pdf,True,81KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222626.pdf,True,116KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 13, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222628.pdf,True,810KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the July 14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222629.pdf,True,764KB
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Slides for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm224718.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241505.pdf,True,139KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","May 12, 2010: Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm203426.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM211394.pdf,True,45KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the May 12, 2010 Joint Meeting of the Arthritis Advisory Commitee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM211396.pdf,True,59KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm211459.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212675.pdf,True,41KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212676.pdf,True,40KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM212677.pdf,True,38KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm212678.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM214828.pdf,True,57KB
Drug Safety and Risk Management Advisory Committee,2010,2010-05-12,"May 12, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM214829.pdf,True,757KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","April 22, 2010: Joint Meeting of the Anesthetic and Life Support Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm205043.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm209140.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209148.pdf,True,323KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209149.pdf,True,289KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM209150.pdf,True,305KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210847.pdf,True,93KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210848.pdf,True,83KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM210850.pdf,True,118KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm210851.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220274.pdf,True,96KB
Drug Safety and Risk Management Advisory Committee,2010,2010-04-22,"April 22, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the April 22, 2010 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM220275.pdf,True,910KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","March 10-11, 2010: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm199871.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203166.pdf,True,77KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203167.pdf,True,277KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203168.pdf,True,93KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm202692.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206716.pdf,True,77KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206718.pdf,True,68KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206719.pdf,True,82KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm206720.htm,False,
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM209117.pdf,True,221KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the March 10, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM209122.pdf,True,656KB
Drug Safety and Risk Management Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the March 11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403223857/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM209124.pdf,True,522KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","December 8, 2009: Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm186142.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm190843.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192844.pdf,True,62KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Roster for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM192845.pdf,True,61KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196212.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196213.pdf,True,50KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM196214.pdf,True,46KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm196216.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM197768.pdf,True,586KB
Drug Safety and Risk Management Advisory Committee,2009,2009-12-08,"December 8, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the December 8, 2009 Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committees",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM236119.pdf,True,51KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","September 24, 2009: Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm181088.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Agenda for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183201.pdf,True,55KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Roster for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183202.pdf,True,70KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm183203.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM183206.pdf,True,54KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript (Open Session) for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187082.pdf,True,479KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187629.pdf,True,116KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248773.pdf,True,61KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248774.pdf,True,54KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-24,"September 24, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 24, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm248775.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","September 23, 2009: Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm176521.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Agenda for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182976.pdf,True,59KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Roster for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182975.pdf,True,62KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Committee Roster for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM182984.pdf,True,47KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm183033.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Questions for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM182977.pdf,True,52KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm187486.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187490.pdf,True,471KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM187630.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248760.pdf,True,61KB
Drug Safety and Risk Management Advisory Committee,2009,2009-09-23,"September 23, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the September 23, 2009 Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM248763.pdf,True,44KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","June 29-30, 2009: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee: Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm143083.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM169006.pdf,True,67KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Roster for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM169007.pdf,True,93KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm161515.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Questions and Vote Results for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM170188.pdf,True,806KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 29, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm171562.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the June 30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm171595.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Copies of packing labels provided for the Committee Members to examine during the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM172107.pdf,True,695KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Submitting Comments to the FDA regarding the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM172110.pdf,True,66KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Written comments from the public received on or before June 8, 2009 that were provided to the committee before the Advisory Committee meeting",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM174694.pdf,True,3.9MB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Transcript for the June 29, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM174697.pdf,True,969KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Meeting Transcript for the June 30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM174699.pdf,True,830KB
Drug Safety and Risk Management Advisory Committee,2009,,"June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the June 29-30, 2009 Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM179888.pdf,True,181KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","January 30, 2009: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm119906.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Agenda for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM143891.pdf,True,85KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Agenda for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM143899.pdf,True,87KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Meeting Roster for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committe and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM143921.pdf,True,97KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Draft Meeting Roster for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM143928.pdf,True,98KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Briefing Information for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm143930.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Final Questions for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM120015.pdf,True,48KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Written Statement for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm120018.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Slides for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm120036.htm,False,
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Transcript: Part 1 for the January 30, 2009 Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committeee",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM120095.pdf,True,532KB
Drug Safety and Risk Management Advisory Committee,2009,2009-01-30,"January 30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee","Minutes for the January 30, 2009 Joint Meeting of the Anesthetic",https://wayback.archive-it.org/7993/20170403223902/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM236238.pdf,True,71KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","June 28, 2016: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm506316.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Waiver for Conflicts of Interest for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm507726.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM508420.pdf,True,53KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm508421.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM510013.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM510014.pdf,True,40KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM510015.pdf,True,34KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm510016.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM518911.pdf,True,34KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-06-28,"June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the June 28, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM522096.pdf,True,804KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","UPDATED MEETING DATE: May 25, 2016: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491151.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM502555.pdf,True,50KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM502556.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm502557.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM506133.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM506134.pdf,True,37KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM506135.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm506136.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM518186.pdf,True,51KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-25,"May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the May 25, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM518287.pdf,True,839KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","UPDATED MEETING DATE: May 24, 2016: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm491057.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM502066.pdf,True,50KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM502068.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm502072.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM504851.pdf,True,22KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM504852.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM504853.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm504854.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM518185.pdf,True,48KB
Endocrinologic and Metabolic Drugs Advisory Committee,2016,2016-05-24,"May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the May 24, 2016 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223909/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM518286.pdf,True,796KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","December 14, 2015: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm472456.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM476502.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm476504.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM478545.pdf,True,24KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM478546.pdf,True,38KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM478547.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm478548.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM484885.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Audio File for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) (MP3 - 446.5MB)",https://wayback.archive-it.org/7993/20170403223910/http://wayback.archive-it.org/7993/20170113052003/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM491094.mp3,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM484886.pdf,True,792KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-12-14,"December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the December 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM476503.pdf,True,71KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","June 10, 2015: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm445096.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM450070.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm450071.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452348.pdf,True,11KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452349.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452350.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm452351.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM457467.pdf,True,47KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-10,"June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the June 10, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM457468.pdf,True,820KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","June 9, 2015: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm445093.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM449862.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm449863.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452341.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452342.pdf,True,13KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM452343.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm452344.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM457465.pdf,True,43KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-06-09,"June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the June 9, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM457466.pdf,True,865KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","April 14, 2015: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm436451.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM442058.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm442059.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM442065.pdf,True,67KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM444139.pdf,True,40KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the (Morning Session) April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM444140.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the (Afternoon Session) April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM444141.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM444142.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm444143.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM453900.pdf,True,106KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the (Morning Session) April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM453901.pdf,True,505KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-04-14,"April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the (Afternoon Session) April 14, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM453902.pdf,True,384KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","January 12, 2015: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm426272.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM429349.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm429350.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM433594.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM433595.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm433597.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM433596.pdf,True,45KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM435656.pdf,True,821KB
Endocrinologic and Metabolic Drugs Advisory Committee,2015,2015-01-12,"January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the January 12, 2015 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223910/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM435951.pdf,True,49KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","September 12, 2014: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm406291.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413610.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413611.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413612.pdf,True,37KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413613.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm413614.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416164.pdf,True,22KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416165.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416166.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm416167.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM419253.pdf,True,841KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-12,"September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the September 12, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM419254.pdf,True,76KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","September 11, 2014: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm407894.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413312.pdf,True,40KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413313.pdf,True,69KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413314.pdf,True,40KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM413315.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm413316.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416150.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416151.pdf,True,59KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM416152.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm416153.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM421472.pdf,True,137KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-09-11,"September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the September 11, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM421474.pdf,True,874KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","April 1, 2014: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm386716.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM390857.pdf,True,42KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM390858.pdf,True,45KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM390859.pdf,True,41KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM390860.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm390862.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM392909.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM392913.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM392915.pdf,True,32KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm392916.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM397049.pdf,True,81KB
Endocrinologic and Metabolic Drugs Advisory Committee,2014,2014-04-01,"April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the April 1, 2014 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM400452.pdf,True,2MB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","UPDATED: December 12, 2013: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm374477.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378071.pdf,True,48KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378072.pdf,True,33KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378073.pdf,True,58KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378074.pdf,True,24KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm378075.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378080.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM379654.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM379656.pdf,True,24KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM390650.pdf,True,32KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm379657.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM382826.pdf,True,52KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-12,"December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the December 12, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM388936.pdf,True,834KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","UPDATED: December 11, 2013: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371067.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377922.pdf,True,53KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377923.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377924.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377925.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm377927.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377926.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM379644.pdf,True,34KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM379645.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM379646.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm379647.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM382825.pdf,True,61KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-12-11,"December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the December 11, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM388935.pdf,True,881KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","November 19, 2013: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371064.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375120.pdf,True,39KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375121.pdf,True,19KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375413.pdf,True,81KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375123.pdf,True,56KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm375125.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM375124.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377479.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377484.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM377486.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm377494.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM381059.pdf,True,37KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-11-19,"November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the November 19, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM397487.pdf,True,808KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","October 16, 2013: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm365571.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370979.pdf,True,37KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370980.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370981.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370982.pdf,True,58KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm370984.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM370983.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM371752.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM371756.pdf,True,23KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM371757.pdf,True,22KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm371758.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf,True,660KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-10-16,"October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the October 16, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378970.pdf,True,42KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","June 5-6, 2013: Joint Meeting of the Endocrinilogic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm348146.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354850.pdf,True,51KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354851.pdf,True,25KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354894.pdf,True,52KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354853.pdf,True,23KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the June 5-6, 2013 Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354854.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm354858.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM354857.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356304.pdf,True,21KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356305.pdf,True,19KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM356306.pdf,True,18KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm356307.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the June 5-6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369180.pdf,True,47KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the June 5, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369182.pdf,True,899KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,,"June 5-6, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the June 6, 2013 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM369183.pdf,True,787KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","January 10, 2013: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm331503.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334544.pdf,True,47KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334545.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334546.pdf,True,47KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334547.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm334549.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334548.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM336229.pdf,True,34KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM336231.pdf,True,22KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM336232.pdf,True,32KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm336233.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM339293.pdf,True,59KB
Endocrinologic and Metabolic Drugs Advisory Committee,2013,2013-01-10,"January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the January 10, 2013 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223914/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM347614.pdf,True,1.9MB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","November 8, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm323208.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Waiver for Conflicts of Interest for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm325469.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327009.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327010.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327011.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327012.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm327014.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM327013.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330918.pdf,True,13KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330920.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330921.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm330922.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340145.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the November 8, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340146.pdf,True,635KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","November 7, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm324213.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM326801.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM326802.pdf,True,74KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM326804.pdf,True,21KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM326806.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM326808.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm326809.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330782.pdf,True,11KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330783.pdf,True,63KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM330785.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm330786.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340373.pdf,True,111KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-11-07,"November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the November 7, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340375.pdf,True,509KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","October 18, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm315828.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323920.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323921.pdf,True,86KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323922.pdf,True,33KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323923.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323924.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm323925.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325939.pdf,True,11KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325940.pdf,True,74KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325941.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm325943.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM342613.pdf,True,32KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-18,"October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the October 18, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM342614.pdf,True,552KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","October 17, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm315641.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323835.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323836.pdf,True,26KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323837.pdf,True,42KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323838.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM323839.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm323840.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325876.pdf,True,11KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325877.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM325878.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm325879.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340367.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-10-17,"October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the October 17, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM340371.pdf,True,586KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","May 10, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm296516.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Waivers for Conflicts of Interest for the May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm301726.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303202.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303205.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303382.pdf,True,38KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the May 10, 2012 for the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303204.pdf,True,19KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm303193.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM305358.pdf,True,18KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM305360.pdf,True,14KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM305361.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm305362.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM309521.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-05-10,"May 10, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the May 10, 2012 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM309522.pdf,True,2MB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","March 28-29, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm290808.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM297234.pdf,True,46KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM297235.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM297236.pdf,True,52KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM297237.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM297238.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm297239.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM299125.pdf,True,18KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM299126.pdf,True,13KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM299129.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm299130.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303352.pdf,True,45KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the March 28, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM303355.pdf,True,3.4MB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,,"March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the March 29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM317370.pdf,True,1.8MB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","February 22, 2012: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm285136.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292309.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292310.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292311.pdf,True,50KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292312.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM292313.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm292314.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM293898.pdf,True,27KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM293901.pdf,True,13KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM293902.pdf,True,34KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm293903.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM304401.pdf,True,28KB
Endocrinologic and Metabolic Drugs Advisory Committee,2012,2012-02-22,"February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the February 22, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223915/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM304402.pdf,True,676KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","November 2, 2011: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm271163.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM277644.pdf,True,20KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM277645.pdf,True,42KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM277646.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM277647.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm277648.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM279277.pdf,True,12KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM279283.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM279291.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm279292.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM290774.pdf,True,35KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the November 2, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM290775.pdf,True,1.7MB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","July 19, 2011: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm258559.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Waivers for Conflicts of Interest for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm261642.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262988.pdf,True,44KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262990.pdf,True,23KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262991.pdf,True,49KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262992.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm262993.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM264305.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM264308.pdf,True,16KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM264310.pdf,True,36KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm264311.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM268726.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-07-19,"July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM268727.pdf,True,598KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","May 19, 2011: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm252887.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM255543.pdf,True,39KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM255545.pdf,True,29KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM255547.pdf,True,48KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM255548.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm255549.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM258115.pdf,True,35KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM258116.pdf,True,18KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM258117.pdf,True,63KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm258118.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM261162.pdf,True,51KB
Endocrinologic and Metabolic Drugs Advisory Committee,2011,2011-05-19,"May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the May 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223919/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM261163.pdf,True,619KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","December 7, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm230339.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235665.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235666.pdf,True,62KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235667.pdf,True,102KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235668.pdf,True,74KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Webcast Information for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235669.pdf,True,11KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm235670.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM237328.pdf,True,77KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM237329.pdf,True,69KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM237330.pdf,True,85KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm237331.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM239926.pdf,True,791KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-12-07,"December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the December 7, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241508.pdf,True,99KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","September 15-16, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm221719.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225566.pdf,True,78KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225567.pdf,True,81KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225568.pdf,True,98KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm225569.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225623.pdf,True,78KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225624.pdf,True,81KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM225627.pdf,True,91KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm225628.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm228700.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm248403.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM232442.pdf,True,1MB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM232443.pdf,True,901KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241506.pdf,True,99KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241507.pdf,True,94KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM228696.pdf,True,80KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269423.pdf,True,78KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM228698.pdf,True,68KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269424.pdf,True,66KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM228699.pdf,True,82KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"September 15-16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the September 16, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269425.pdf,True,76KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","July 15, 2010:  Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214795.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm218819.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218816.pdf,True,88KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218817.pdf,True,320KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218818.pdf,True,99KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM224180.pdf,True,924KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM227044.pdf,True,76KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM227047.pdf,True,113KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM227048.pdf,True,82KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm227049.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-07-15,"July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the July 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM230582.pdf,True,148KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","July 1314, 2010: Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm214612.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218478.pdf,True,128KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218479.pdf,True,285KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Pre-Meeting Posting of Slides for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm218481.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm218491.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM218527.pdf,True,135KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222622.pdf,True,115KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222625.pdf,True,81KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222626.pdf,True,116KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the July 13, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222628.pdf,True,810KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the July 14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM222629.pdf,True,764KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Slides for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm224718.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"July 13-14, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the July 13-14, 2010 Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241505.pdf,True,139KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","May 27, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm205566.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm213220.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM213255.pdf,True,77KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM213256.pdf,True,78KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM213257.pdf,True,97KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Committee Roster for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM213258.pdf,True,76KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM224181.pdf,True,949KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM230581.pdf,True,116KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-05-27,"May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm242615.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,2010-02-24,"February 24, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee - Cancelled","Meeting Cancelled - February 24, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm198208.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","January 12-13, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm191156.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm196755.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196759.pdf,True,37KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196760.pdf,True,31KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196761.pdf,True,270KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Committee Roster for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196763.pdf,True,236KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm196833.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196844.pdf,True,65KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196845.pdf,True,30KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196849.pdf,True,48KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Committee Roster for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM196850.pdf,True,236KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript Index for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200710.pdf,True,301KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200711.pdf,True,484KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript Index for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200612.pdf,True,278KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200613.pdf,True,471KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241539.pdf,True,49KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241504.pdf,True,53KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm248668.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides from the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm248679.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269385.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Agenda for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269409.pdf,True,12KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269386.pdf,True,17KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269410.pdf,True,21KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the January 12, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269388.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2010,,"January 12-13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Meeting Roster for the January 13, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223921/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM269411.pdf,True,15KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","December 15, 2009: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm187991.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm193829.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Agenda for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM193834.pdf,True,55KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Questions for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM193835.pdf,True,87KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Meeting Roster for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM193836.pdf,True,51KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Draft Committee Roster for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM193837.pdf,True,52KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm194913.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM194920.pdf,True,202KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript Index for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200610.pdf,True,351KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM200611.pdf,True,560KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the December 15, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM241503.pdf,True,119KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","April 1-2, 2009: Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm136239.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Agenda for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM136368.pdf,True,60KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148604.pdf,True,49KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Meeting Roster for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148078.pdf,True,62KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm148080.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Questions for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148567.pdf,True,62KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Agenda for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148571.pdf,True,60KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Committee Roster for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148588.pdf,True,56KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Meeting Roster for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148598.pdf,True,53KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Briefing Information for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm148608.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM149215.pdf,True,173KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Final Questions for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM149222.pdf,True,231KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Questions for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148682.pdf,True,70KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm149225.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Slides for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm149606.htm,False,
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the April 1, 2009 Meeting of the Endocrinology and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM151169.pdf,True,484KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Transcript for the April 2, 2009 Meeting of the Endocrinology and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM151176.pdf,True,625KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the April 1, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM192026.pdf,True,74KB
Endocrinologic and Metabolic Drugs Advisory Committee,2009,,"April 1- 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee","Minutes for the April 2, 2009 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223925/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM192028.pdf,True,91KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","April 7, 2016: Meeting of the Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm486118.htm,False,
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM494105.pdf,True,24KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm494107.htm,False,
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Webcast Information for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM494106.pdf,True,43KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM496614.pdf,True,25KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM496615.pdf,True,14KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM496616.pdf,True,26KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm496618.htm,False,
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM497186.pdf,True,44KB
Gastrointestinal Drugs Advisory Committee,2016,2016-04-07,"April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the April 7, 2016 Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC)",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM510039.pdf,True,696KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","UPDATED AGENDA INFORMATION: December 9, 2013: Joint Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC) and Drug Safety and Risk Management Advisory Committee (DSaRM) Meeting Announcement",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371059.htm,False,
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377607.pdf,True,70KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377608.pdf,True,72KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377609.pdf,True,54KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Gastrointestinal Drugs Advisory Committee Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377610.pdf,True,19KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377612.pdf,True,17KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm377615.htm,False,
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Webcast Information for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM377614.pdf,True,42KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378741.pdf,True,53KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378745.pdf,True,64KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM378747.pdf,True,31KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm378750.htm,False,
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM384619.pdf,True,145KB
Gastrointestinal Drugs Advisory Committee,2013,2013-12-09,"December 9, 2013 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the December 9, 2013 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223935/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM390834.pdf,True,680KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","October 16, 2012: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm316682.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM323492.pdf,True,44KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM323494.pdf,True,45KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM323496.pdf,True,59KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM323498.pdf,True,18KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Webcast Information for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM323501.pdf,True,29KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm323503.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM324957.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM324959.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM324960.pdf,True,42KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm324961.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM326473.pdf,True,33KB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-16,"October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the October 16, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM330607.pdf,True,1.5MB
Gastrointestinal Drugs Advisory Committee,2012,2012-10-15,"October 15, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","POSTPONED: October 15, 2012: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm315829.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","August 28, 2012: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm309405.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM316781.pdf,True,44KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM316922.pdf,True,46KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM316782.pdf,True,59KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM316784.pdf,True,18KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm316785.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM318073.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM318074.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM318075.pdf,True,42KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm318076.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM319690.pdf,True,35KB
Gastrointestinal Drugs Advisory Committee,2012,2012-08-28,"August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the August 28, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM330601.pdf,True,674KB
Gastrointestinal Drugs Advisory Committee,2012,2012-05-31,"May 31, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","CANCELLED May 31, 2012: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm297388.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","March 13, 2012: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm291606.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Waivers for Conflicts of Interest for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm293386.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM295381.pdf,True,46KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM295382.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM295383.pdf,True,55KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM295384.pdf,True,22KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm295385.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM297992.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM297993.pdf,True,36KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM297994.pdf,True,45KB
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm297996.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript and Addendum to the Transcript for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm333175.htm,False,
Gastrointestinal Drugs Advisory Committee,2012,2012-03-13,"March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223936/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM308463.pdf,True,27KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","November 17, 2011: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273380.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279729.pdf,True,54KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279731.pdf,True,25KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279733.pdf,True,51KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279734.pdf,True,19KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm279735.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281527.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281529.pdf,True,20KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281530.pdf,True,33KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm281531.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM286759.pdf,True,698KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-17,"November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the November 17, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM288707.pdf,True,22KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","November 16, 2011: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm273371.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279545.pdf,True,53KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279553.pdf,True,23KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279559.pdf,True,38KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM279567.pdf,True,19KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm279642.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281487.pdf,True,37KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281488.pdf,True,18KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM281491.pdf,True,24KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm281493.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM283342.pdf,True,738KB
Gastrointestinal Drugs Advisory Committee,2011,2011-11-16,"November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the November 16, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM283448.pdf,True,32KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","July 21, 2011: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm257791.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Waivers for Conflicts of Interest for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm261883.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263451.pdf,True,24KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263453.pdf,True,20KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263454.pdf,True,37KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263455.pdf,True,19KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm263456.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM266691.pdf,True,16KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM266692.pdf,True,22KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM266693.pdf,True,24KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm266695.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM271750.pdf,True,50KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-21,"July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the July 21, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM271751.pdf,True,689KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","July 20, 2011: Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm260716.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263172.pdf,True,20KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263174.pdf,True,39KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM263173.pdf,True,19KB
Gastrointestinal Drugs Advisory Committee,2011,2011-07-20,"July 20, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the July 20, 2011 Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM272026.pdf,True,87KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","January 12, 2011: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm235513.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM239366.pdf,True,31KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM239367.pdf,True,34KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Committee Roster for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM239368.pdf,True,24KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM239369.pdf,True,80KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Webcast Information for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM239371.pdf,True,13KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm239372.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM240594.pdf,True,34KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM240595.pdf,True,22KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM240596.pdf,True,70KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm240597.htm,False,
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM242264.pdf,True,104KB
Gastrointestinal Drugs Advisory Committee,2011,2011-01-12,"January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the January 12, 2011 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223937/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM243290.pdf,True,671KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","November 5, 2010: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm227991.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Waivers for Conflicts of Interest for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm230388.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM232022.pdf,True,71KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM232023.pdf,True,63KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM232024.pdf,True,80KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm232025.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233771.pdf,True,64KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233772.pdf,True,57KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233773.pdf,True,70KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm233774.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM235453.pdf,True,81KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-05,"November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the November 5, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM237495.pdf,True,986KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","November 4, 2010: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm228450.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM231983.pdf,True,69KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM231984.pdf,True,68KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM231986.pdf,True,77KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm231987.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233761.pdf,True,65KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233762.pdf,True,61KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM233763.pdf,True,66KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm233764.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM235452.pdf,True,83KB
Gastrointestinal Drugs Advisory Committee,2010,2010-11-04,"November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the November 4, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM237496.pdf,True,762KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","February 23, 2010: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm195279.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM200982.pdf,True,64KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Meeting Roster for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM200985.pdf,True,76KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Questions for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM200987.pdf,True,62KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm200988.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Agenda for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM203240.pdf,True,64KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Questions for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM203241.pdf,True,101KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Final Meeting Roster for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM203242.pdf,True,68KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm203243.htm,False,
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM206727.pdf,True,131KB
Gastrointestinal Drugs Advisory Committee,2010,2010-02-23,"February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the February 23, 2010 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223941/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM206728.pdf,True,447KB
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","May 19, 2009: Gastrointestinal Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm152387.htm,False,
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Draft Agenda for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM152393.pdf,True,41KB
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Meeting Roster for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM152395.pdf,True,51KB
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Briefing Information for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm152396.htm,False,
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Minutes for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee(XML - 0KB)",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM191907.xml,False,
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Transcript for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM191908.pdf,True,454KB
Gastrointestinal Drugs Advisory Committee,2009,2009-05-19,"May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee","Slides for the May 19, 2009 Meeting of the Gastrointestinal Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223944/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/ucm191924.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","May 3, 2013: Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm341085.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Agenda for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350136.pdf,True,45KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Questions for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350138.pdf,True,20KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Meeting Roster for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350139.pdf,True,185KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Committee Roster for the May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350141.pdf,True,23KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Committee Roster for the May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350142.pdf,True,30KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Briefing Information for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm350145.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Webcast Information for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350144.pdf,True,28KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Agenda for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351826.pdf,True,192KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Questions for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351828.pdf,True,78KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Meeting Roster for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351829.pdf,True,172KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Slides for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm351830.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Minutes for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM363898.pdf,True,176KB
Medical Imaging Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Transcript for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM363899.pdf,True,779KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","February 14, 2013: Medical Imaging Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm334173.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Agenda for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM339369.pdf,True,102KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Questions for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM339370.pdf,True,277KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Draft Meeting Roster for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM339371.pdf,True,184KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Committee Roster for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM339372.pdf,True,94KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Briefing Information for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm339374.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Webcast Information for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM339373.pdf,True,27KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Agenda for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM341055.pdf,True,188KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Questions for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM341057.pdf,True,75KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Final Meeting Roster for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM341063.pdf,True,208KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Slides for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm341064.htm,False,
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Minutes for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM346947.pdf,True,194KB
Medical Imaging Drugs Advisory Committee,2013,2013-02-14,"February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee","Transcript for the February 14, 2013 Meeting of the Medical Imaging Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403223953/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM352148.pdf,True,696KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","April 4, 2017: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm544701.htm,False,
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549884.pdf,True,34KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549885.pdf,True,20KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549886.pdf,True,63KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549887.pdf,True,25KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM549888.pdf,True,25KB
Nonprescription Drugs Advisory Committee,2017,2017-04-04,"April 4, 2017 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403223956/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm549889.htm,False,
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","April 15, 2016: Meeting of the Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm487168.htm,False,
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM495794.pdf,True,24KB
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm495795.htm,False,
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM498770.pdf,True,26KB
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM498771.pdf,True,15KB
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM498772.pdf,True,24KB
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm498773.htm,False,
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM506325.pdf,True,612KB
Nonprescription Drugs Advisory Committee,2016,2016-04-15,"April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the April 15, 2016 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM509889.pdf,True,43KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","September 4-5, 2014: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm407137.htm,False,
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm410304.htm,False,
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412319.pdf,True,88KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412320.pdf,True,24KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412321.pdf,True,81KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412322.pdf,True,32KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM415403.pdf,True,33KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM415405.pdf,True,18KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM415406.pdf,True,31KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm415407.htm,False,
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421304.pdf,True,47KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the September 4, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421305.pdf,True,726KB
Nonprescription Drugs Advisory Committee,2014,,"September 4-5, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the September 5, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421306.pdf,True,398KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","September 3, 2014: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm407136.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm410287.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412164.pdf,True,32KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412165.pdf,True,18KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412166.pdf,True,35KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412167.pdf,True,27KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Webcast Information for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM412168.pdf,True,68KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM414578.pdf,True,25KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM414622.pdf,True,13KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM414579.pdf,True,46KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm414580.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421120.pdf,True,39KB
Nonprescription Drugs Advisory Committee,2014,2014-09-03,"September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the September 3, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM421121.pdf,True,741KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","May 2, 2014: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm393018.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the May 02, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395167.pdf,True,40KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the May 02, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395168.pdf,True,20KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the May 02, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395169.pdf,True,79KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the May 02, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395170.pdf,True,40KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the May 02, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm395171.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM397075.pdf,True,34KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM397076.pdf,True,14KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM397078.pdf,True,67KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm397080.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM402352.pdf,True,725KB
Nonprescription Drugs Advisory Committee,2014,2014-05-02,"May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the May 2, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM404353.pdf,True,47KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","February 26, 2014: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380906.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm385213.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386950.pdf,True,33KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386951.pdf,True,17KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386952.pdf,True,86KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386953.pdf,True,32KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Webcast Information for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386954.pdf,True,67KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388206.pdf,True,24KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388208.pdf,True,10KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388209.pdf,True,120KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm388211.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395526.pdf,True,37KB
Nonprescription Drugs Advisory Committee,2014,2014-02-26,"February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM400253.pdf,True,435KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","February 25, 2014: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380886.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386668.pdf,True,41KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386669.pdf,True,19KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386670.pdf,True,74KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386671.pdf,True,32KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Pulmonary-Allergy Drugs Advisory Committee Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386672.pdf,True,32KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm386673.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Webcast Information for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386674.pdf,True,68KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388044.pdf,True,29KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388045.pdf,True,14KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388047.pdf,True,154KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm388048.htm,False,
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395525.pdf,True,62KB
Nonprescription Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403223957/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM400231.pdf,True,778KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","July 31, 2013: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm359032.htm,False,
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM362804.pdf,True,93KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM362805.pdf,True,18KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM362806.pdf,True,63KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM362807.pdf,True,31KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm362808.htm,False,
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM363955.pdf,True,88KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM363957.pdf,True,12KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM363958.pdf,True,70KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm363959.htm,False,
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM371010.pdf,True,93KB
Nonprescription Drugs Advisory Committee,2013,2013-07-31,"July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the July 31, 2013 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)",https://wayback.archive-it.org/7993/20170403224002/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM372371.pdf,True,1.9MB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","November 9, 2012: Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm317757.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM327154.pdf,True,28KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM327155.pdf,True,19KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM327156.pdf,True,31KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Committee Roster for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM327157.pdf,True,18KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm327159.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Webcast Information for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM327158.pdf,True,29KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM330958.pdf,True,19KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM330959.pdf,True,13KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM330960.pdf,True,16KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm330964.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM334801.pdf,True,25KB
Nonprescription Drugs Advisory Committee,2012,2012-11-09,"November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the November 9, 2012 Meeting of the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM336189.pdf,True,1.6MB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","April 2, 2012: Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm293595.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297755.pdf,True,50KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297756.pdf,True,19KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297757.pdf,True,64KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Anti-Infective Drugs Advisory Committee Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297758.pdf,True,18KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM297759.pdf,True,20KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm297760.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299206.pdf,True,35KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299207.pdf,True,13KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM299208.pdf,True,40KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Slides for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/ucm299209.htm,False,
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304651.pdf,True,23KB
Nonprescription Drugs Advisory Committee,2012,2012-04-02,"April 2, 2012 Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224004/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM304653.pdf,True,624KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","May 17-18, 2011: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm246426.htm,False,
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Draft Agenda for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM255300.pdf,True,46KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Draft Questions for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM255301.pdf,True,23KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Draft Meeting Roster for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM255302.pdf,True,47KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM255303.pdf,True,22KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Pediatric Advisory Committee Roster for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM255304.pdf,True,25KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Briefing Information for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm255305.htm,False,
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Final Agenda for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM256564.pdf,True,30KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Final Questions for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM256565.pdf,True,14KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Final Meeting Roster for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM256567.pdf,True,35KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Slides for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm256568.htm,False,
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Minutes for the May 17-18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM264147.pdf,True,49KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the May 17, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM264148.pdf,True,728KB
Nonprescription Drugs Advisory Committee,2011,,"May 17-18, 2011, Meeting of the Nonprescription Drugs Advisory Committee","Transcript for the May 18, 2011 Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee",https://wayback.archive-it.org/7993/20170403224006/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM264149.pdf,True,380KB
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","UPDATED INFORMATION: March 29, 2017: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm547160.htm,False,
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM548654.pdf,True,30KB
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM548655.pdf,True,35KB
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM548656.pdf,True,33KB
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM548657.pdf,True,26KB
Oncologic Drugs Advisory Committee,2017,2017-03-29,"March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the March 29, 2017 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224013/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm548658.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","UPDATED LOCATION INFORMATION: September 14, 2016: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm513937.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM520091.pdf,True,26KB
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm520092.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM522812.pdf,True,21KB
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM522813.pdf,True,21KB
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM522814.pdf,True,23KB
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Slides for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm522815.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM525763.pdf,True,35KB
Oncologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 14, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM529118.pdf,True,462KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","UPDATED INFORMATION: June 28-29, 2016: Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm507434.htm,False,
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Waiver for Conflicts of Interest for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm508860.htm,False,
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm508661.htm,False,
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM508689.pdf,True,25KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM508690.pdf,True,72KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM511759.pdf,True,130KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM511761.pdf,True,40KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM511763.pdf,True,46KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Summary Minutes for the June 28-29, 2016 Meeting of Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM514739.pdf,True,144KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 28, 2016 Meeting of Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM516504.pdf,True,351KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 28, 2016 Meeting of Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM516505.pdf,True,213KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 29, 2016 Meeting of Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM516506.pdf,True,415KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 29, 2016 Meeting of Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM516507.pdf,True,413KB
Oncologic Drugs Advisory Committee,2016,,"June 28-29, 2016 Meeting of the Oncologic Drugs Advisory Committee","Slides for the June 28-29, 2016 Meeting of the Pediatric Subcommittee of the Oncologic Drugs Advisory Committee (pedsODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm516795.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","April 12, 2016: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm486391.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM494778.pdf,True,24KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm494781.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM494779.pdf,True,64KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM496625.pdf,True,78KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM496626.pdf,True,110KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM496627.pdf,True,26KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Slides for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm496628.htm,False,
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM507560.pdf,True,434KB
Oncologic Drugs Advisory Committee,2016,2016-04-12,"April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the April 12, 2016 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224014/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM510286.pdf,True,163KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","November 19, 2015: Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm463242.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM472965.pdf,True,23KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm472967.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM472966.pdf,True,68KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM474495.pdf,True,21KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) (Session 1)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM474497.pdf,True,47KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) (Session 2)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM474498.pdf,True,46KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM474499.pdf,True,24KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Slides for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm474500.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM478962.pdf,True,59KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) (Session 1)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM479914.pdf,True,282KB
Oncologic Drugs Advisory Committee,2015,2015-11-19,"November 19, 2015 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 19, 2015 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) (Session 2)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM479916.pdf,True,198KB
Oncologic Drugs Advisory Committee,2015,2015-11-18,"November 18, 2015 Meeting of the Oncologic Drugs Advisory Committee","November 18, 2015: Joint Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee and Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm464319.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","July 9, 2015: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm448239.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM453749.pdf,True,23KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm453751.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM453750.pdf,True,64KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM454739.pdf,True,20KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM454740.pdf,True,28KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM454741.pdf,True,23KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm454742.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM457542.pdf,True,30KB
Oncologic Drugs Advisory Committee,2015,2015-07-09,"July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 9, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM459508.pdf,True,393KB
Oncologic Drugs Advisory Committee,2015,2015-04-29,"April 29, 2015 Meeting of the Oncologic Drugs Advisory Committee","April 29, 2015: Joint Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee and Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm433807.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","January 7, 2015: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm426350.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the January 7, 2014 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM428777.pdf,True,28KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm428779.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the January 7, 2014 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM428778.pdf,True,43KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM431113.pdf,True,29KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM431114.pdf,True,26KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM431115.pdf,True,27KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Slides for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm431116.htm,False,
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM436385.pdf,True,41KB
Oncologic Drugs Advisory Committee,2015,2015-01-07,"January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the January 7, 2015 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM436387.pdf,True,736KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","December 11, 2014: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm421987.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM426169.pdf,True,33KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM426170.pdf,True,72KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM426171.pdf,True,30KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM426172.pdf,True,25KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm426174.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM426173.pdf,True,17KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430862.pdf,True,28KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430863.pdf,True,58KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430866.pdf,True,25KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm430869.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM436346.pdf,True,46KB
Oncologic Drugs Advisory Committee,2014,2014-12-11,"December 11, 2014 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 11, 2014 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM439648.pdf,True,644KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","November 6, 2014: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm418352.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421617.pdf,True,45KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - AM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421618.pdf,True,24KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - PM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421661.pdf,True,30KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421619.pdf,True,38KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421620.pdf,True,25KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm421622.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM421621.pdf,True,43KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM424019.pdf,True,30KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - AM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM424020.pdf,True,21KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - PM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM424022.pdf,True,27KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM424023.pdf,True,31KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Slides for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm424042.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430826.pdf,True,62KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - AM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430828.pdf,True,463KB
Oncologic Drugs Advisory Committee,2014,2014-11-06,"November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 6, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - PM Session",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM430829.pdf,True,452KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","June 25, 2014: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm394126.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM402201.pdf,True,24KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM402202.pdf,True,32KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM402203.pdf,True,29KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM402204.pdf,True,18KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm402206.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM402205.pdf,True,42KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM404163.pdf,True,22KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM404165.pdf,True,34KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM404166.pdf,True,27KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Slides for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm404167.htm,False,
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM405756.pdf,True,33KB
Oncologic Drugs Advisory Committee,2014,2014-06-25,"June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 25, 2014 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224015/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM410457.pdf,True,1.4MB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","November 5, 2013: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm370991.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Agenda for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373157.pdf,True,37KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Questions for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373158.pdf,True,66KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373401.pdf,True,35KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Committee Roster for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373161.pdf,True,32KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Briefing Information for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm373164.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Webcast Information for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373163.pdf,True,43KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Agenda for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375630.pdf,True,30KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Questions for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375633.pdf,True,59KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375634.pdf,True,21KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Slides for the November 5, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm375637.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Minutes for the November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM378968.pdf,True,59KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Transcript for the November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM399015.pdf,True,528KB
Oncologic Drugs Advisory Committee,2013,2013-11-05,"November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Transcript for the November 5, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM399016.pdf,True,677KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","November 4, 2013: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm370990.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Agenda for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373026.pdf,True,34KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Questions for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373027.pdf,True,19KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373029.pdf,True,35KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Committee Roster for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373030.pdf,True,32KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Briefing Information for the November 4, 2013 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm373032.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Webcast Information for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM373031.pdf,True,15KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Agenda for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375584.pdf,True,26KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Questions for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375585.pdf,True,13KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM375586.pdf,True,20KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Slides for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm375587.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Minutes for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM378967.pdf,True,37KB
Oncologic Drugs Advisory Committee,2013,2013-11-04,"November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee","Transcript for the November 4, 2013 Meeting of the Pediatric Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM399014.pdf,True,307KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","September 12, 2013: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm364526.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM367748.pdf,True,16KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM367749.pdf,True,18KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM367750.pdf,True,33KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM367751.pdf,True,33KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm367753.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM367752.pdf,True,17KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM370054.pdf,True,19KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM370055.pdf,True,26KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM370056.pdf,True,23KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Slides for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm370058.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM371011.pdf,True,60KB
Oncologic Drugs Advisory Committee,2013,2013-09-12,"September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 12, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM377714.pdf,True,1.5MB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","May 3, 2013: Joint Meeting of the Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm341085.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350136.pdf,True,45KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350138.pdf,True,20KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350139.pdf,True,185KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350142.pdf,True,30KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the May 3, 2013 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350141.pdf,True,23KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm350145.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM350144.pdf,True,28KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351826.pdf,True,192KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351828.pdf,True,78KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM351829.pdf,True,172KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Slides for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm351830.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM363898.pdf,True,176KB
Oncologic Drugs Advisory Committee,2013,2013-05-03,"May 3, 2013 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the May 3, 2013 Joint Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) and Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/MedicalImagingDrugsAdvisoryCommittee/UCM363899.pdf,True,779KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","May 2, 2013: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm341452.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm348423.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350068.pdf,True,22KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350069.pdf,True,18KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350070.pdf,True,18KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350071.pdf,True,39KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350072.pdf,True,32KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm350074.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM350073.pdf,True,15KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM351315.pdf,True,22KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM351317.pdf,True,12KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM351318.pdf,True,12KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM351319.pdf,True,21KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Slides for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm351320.htm,False,
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM359160.pdf,True,28KB
Oncologic Drugs Advisory Committee,2013,2013-05-02,"May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the May 2, 2013 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224016/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM359161.pdf,True,853KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","December 4, 2012: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm319672.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM330198.pdf,True,47KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM330199.pdf,True,40KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM330200.pdf,True,38KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM330201.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm330203.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM330202.pdf,True,31KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM332072.pdf,True,32KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM332073.pdf,True,21KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM332075.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 4, 2012 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm332076.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 4, 2012 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM336607.pdf,True,599KB
Oncologic Drugs Advisory Committee,2012,2012-12-04,"December 4, 2012 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 4, 2012 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM338985.pdf,True,34KB
Oncologic Drugs Advisory Committee,2012,2012-11-08,"November 8, 2012 Meeting of the Oncologic Drugs Advisory Committee","CANCELLED: November 8, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm320255.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","July 25, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm305517.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312921.pdf,True,30KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312922.pdf,True,19KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312923.pdf,True,36KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312924.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312949.pdf,True,13KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm312950.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM314033.pdf,True,20KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM314034.pdf,True,13KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM315147.pdf,True,21KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm314039.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Webcast Recording of the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee (ODAC)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm314045.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM316460.pdf,True,18KB
Oncologic Drugs Advisory Committee,2012,2012-07-25,"July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM320635.pdf,True,382KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","CANCELLED MORNING SESSION; AFTERNOON SESSION TO TAKE PLACE FROM 9 AM-3PM.  July 24, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm306471.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","DUE TO THE CANCELLATION OF THE MEETING TOPIC FOR WHICH THIS WAIVER APPLIED, THE WAIVER IS WITHDRAWN: Waivers for Conflicts of Interest for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm310925.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm311140.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312868.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312869.pdf,True,20KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312870.pdf,True,38KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312871.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM312872.pdf,True,13KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM315074.pdf,True,19KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM315075.pdf,True,14KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM315076.pdf,True,22KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm315077.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Recording for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM315084.pdf,True,29KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM316323.pdf,True,27KB
Oncologic Drugs Advisory Committee,2012,2012-07-24,"July 24, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM319529.pdf,True,472KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","June 20, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm302199.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308555.pdf,True,53KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308556.pdf,True,45KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308557.pdf,True,18KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308981.pdf,True,38KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308558.pdf,True,19KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM308559.pdf,True,30KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm308560.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM310849.pdf,True,54KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM310851.pdf,True,49KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM310852.pdf,True,12KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM310853.pdf,True,22KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Slides for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm310854.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM311139.pdf,True,90KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM314708.pdf,True,402KB
Oncologic Drugs Advisory Committee,2012,2012-06-20,"June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM314709.pdf,True,343KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","March 21, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm290531.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296398.pdf,True,15KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296399.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296400.pdf,True,30KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296401.pdf,True,15KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296402.pdf,True,29KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm296403.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298856.pdf,True,18KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298857.pdf,True,12KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298858.pdf,True,19KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Slides for the March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm298859.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM301523.pdf,True,26KB
Oncologic Drugs Advisory Committee,2012,2012-03-21,"March 21, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM304480.pdf,True,399KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","March 20, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm290490.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm294787.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296283.pdf,True,21KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296284.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296285.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm296297.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296389.pdf,True,31KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296390.pdf,True,15KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM296391.pdf,True,30KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298822.pdf,True,24KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298824.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298825.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298826.pdf,True,20KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Slides for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm298827.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM301521.pdf,True,38KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM304478.pdf,True,377KB
Oncologic Drugs Advisory Committee,2012,2012-03-20,"March 20, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM304479.pdf,True,341KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","CANCELLED AFTERNOON SESSION; MORNING SESSION TO TAKE PLACE AS PREVIOUSLY ANNOUNCED. February 9, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm285406.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290500.pdf,True,16KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290502.pdf,True,43KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290773.pdf,True,35KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290504.pdf,True,18KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290506.pdf,True,29KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm290507.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292653.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292654.pdf,True,42KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292656.pdf,True,19KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Slides for the February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm292657.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM293710.pdf,True,71KB
Oncologic Drugs Advisory Committee,2012,2012-02-09,"February 9, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298512.pdf,True,372KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","February 8, 2012: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm285399.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290395.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290396.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290772.pdf,True,35KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290397.pdf,True,18KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM290398.pdf,True,28KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm290399.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292635.pdf,True,15KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292636.pdf,True,15KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM292637.pdf,True,17KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Slides for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm292638.htm,False,
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM293709.pdf,True,27KB
Oncologic Drugs Advisory Committee,2012,2012-02-08,"February 8, 2012  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224017/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM298511.pdf,True,370KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","NEW OPEN PUBLIC HEARING SESSION START TIME: December 7, 2011: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm276936.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282277.pdf,True,49KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282278.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282279.pdf,True,22KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282280.pdf,True,100KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282282.pdf,True,23KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM282283.pdf,True,12KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm282284.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM283650.pdf,True,14KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM283651.pdf,True,53KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM283652.pdf,True,50KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM283654.pdf,True,18KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm283655.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM285876.pdf,True,98KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM288716.pdf,True,308KB
Oncologic Drugs Advisory Committee,2011,2011-12-07,"December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 7, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM288717.pdf,True,401KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","November 2, 2011: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm274396.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277604.pdf,True,29KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277696.pdf,True,26KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277605.pdf,True,42KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277606.pdf,True,22KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277608.pdf,True,14KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm277609.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281038.pdf,True,26KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281040.pdf,True,22KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281042.pdf,True,26KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Slides for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm281043.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281988.pdf,True,43KB
Oncologic Drugs Advisory Committee,2011,2011-11-02,"November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281989.pdf,True,623KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","November 1, 2011: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm274682.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277577.pdf,True,33KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277578.pdf,True,39KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277579.pdf,True,40KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277580.pdf,True,22KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277581.pdf,True,14KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm277582.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281014.pdf,True,33KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281015.pdf,True,25KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281016.pdf,True,22KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Slides for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm281018.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281986.pdf,True,55KB
Oncologic Drugs Advisory Committee,2011,2011-11-01,"November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 1, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM281987.pdf,True,633KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","September 14, 2011: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm265462.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271464.pdf,True,25KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271465.pdf,True,54KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271466.pdf,True,23KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (Ferriprox - AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271467.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (NM-CRPC - PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271468.pdf,True,32KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm271469.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271540.pdf,True,15KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Written Statements for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (Ferriprox-AM session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271676.pdf,True,23.7MB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Additional Written Statements for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (Ferriprox-AM session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271862.pdf,True,4.1MB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Written Statements for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (NM-CRPC- PM session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM271678.pdf,True,68KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM275597.pdf,True,26KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (Ferriprox - AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM275598.pdf,True,54KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (NM-CRPC - PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM275600.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM275601.pdf,True,31KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM275602.pdf,True,101KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Slides for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm275604.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (Ferriprox - AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277462.pdf,True,442KB
Oncologic Drugs Advisory Committee,2011,2011-09-14,"September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (NM-CRPC - PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM277463.pdf,True,445KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","July 14, 2011: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm259804.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262583.pdf,True,24KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262584.pdf,True,31KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262586.pdf,True,25KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262587.pdf,True,28KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262588.pdf,True,23KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM262589.pdf,True,16KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm262590.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM267007.pdf,True,23KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM267009.pdf,True,25KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM267015.pdf,True,19KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm267016.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM268123.pdf,True,49KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM268656.pdf,True,410KB
Oncologic Drugs Advisory Committee,2011,2011-07-14,"July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 14, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM268657.pdf,True,293KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","April 12, 2011: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm245277.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250365.pdf,True,252KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (Novartis)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250367.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (Pfizer)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250368.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250369.pdf,True,28KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250371.pdf,True,32KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250373.pdf,True,16KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm250375.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM251670.pdf,True,54KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (Novartis)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM251671.pdf,True,16KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (Pfizer)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM251672.pdf,True,19KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM251673.pdf,True,18KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Slides for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm251674.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM254187.pdf,True,48KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (AM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM256370.pdf,True,385KB
Oncologic Drugs Advisory Committee,2011,2011-04-12,"April 12, 2011  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the April 12, 2011 Meeting of the Oncologic Drugs Advisory Committee (PM Session)",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM256372.pdf,True,361KB
Oncologic Drugs Advisory Committee,2011,2011-02-09,"February 9, 2011  Meeting of the Oncologic Drugs Advisory Committee","February 9, 2011: Oncologic Drugs Advisory Committee Meeting Announcement - CANCELLED",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm235827.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","February 8, 2011: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm239360.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM242005.pdf,True,60KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM242009.pdf,True,33KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM242010.pdf,True,34KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM242014.pdf,True,32KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM242015.pdf,True,14KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm242016.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM243220.pdf,True,54KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM243221.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM243222.pdf,True,21KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Slides for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm243223.htm,False,
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Transcript for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM245644.pdf,True,747KB
Oncologic Drugs Advisory Committee,2011,2011-02-08,"February 8, 2011  Meeting of the Oncologic Drugs Advisory Committee","Minutes for the February 8, 2011 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224026/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM250472.pdf,True,45KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Amendment to the December 2, 2010: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm234702.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM235072.pdf,True,91KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM235075.pdf,True,87KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM235078.pdf,True,84KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM235186.pdf,True,73KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM235080.pdf,True,65KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm235083.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236803.pdf,True,100KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236805.pdf,True,75KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236806.pdf,True,71KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm236807.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM237499.pdf,True,437KB
Oncologic Drugs Advisory Committee,2010,2010-12-02,"December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 2, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM239356.pdf,True,91KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","December 1, 2010: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm230653.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234928.pdf,True,111KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234930.pdf,True,97KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234931.pdf,True,103KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234932.pdf,True,65KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm234933.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236781.pdf,True,150KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236783.pdf,True,78KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236784.pdf,True,109KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm236785.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM237498.pdf,True,767KB
Oncologic Drugs Advisory Committee,2010,2010-12-01,"December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 1, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM239355.pdf,True,149KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","November 30, 2010: Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm232482.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234752.pdf,True,111KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234924.pdf,True,97KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234755.pdf,True,88KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Webcast Information for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM234827.pdf,True,67KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm234831.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236386.pdf,True,103KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236387.pdf,True,89KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM236388.pdf,True,87KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Slides for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm236389.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM237497.pdf,True,708KB
Oncologic Drugs Advisory Committee,2010,2010-11-30,"November 30, 2010 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the November 30, 2010 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM239509.pdf,True,116KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","July 20, 2010: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm213724.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219221.pdf,True,47KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219452.pdf,True,34KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219222.pdf,True,33KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm219223.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219429.pdf,True,124KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219974.pdf,True,48KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219975.pdf,True,20KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM219976.pdf,True,76KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm219977.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM221998.pdf,True,411KB
Oncologic Drugs Advisory Committee,2010,2010-07-20,"July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 20, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM224753.pdf,True,57KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","March 22, 2010: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm202747.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM204331.pdf,True,56KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM204332.pdf,True,41KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM204333.pdf,True,34KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm204334.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM206077.pdf,True,52KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-AM Session-Cell Therapeutics-Pixantrone",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM206078.pdf,True,59KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-PM Session-ChemGenex-Omapro",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM206079.pdf,True,23KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM206080.pdf,True,24KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Slides for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm206081.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM207638.pdf,True,115KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-AM Session",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM208718.pdf,True,280KB
Oncologic Drugs Advisory Committee,2010,2010-03-22,"March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 22, 2010 Meeting of the Oncologic Drugs Advisory Committee-PM Session",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM208719.pdf,True,268KB
Oncologic Drugs Advisory Committee,2010,2010-02-10,"POSTPONED: February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee","POSTPONED February 10, 2010: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm195221.htm,False,
Oncologic Drugs Advisory Committee,2010,2010-02-10,"POSTPONED: February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM199556.pdf,True,57KB
Oncologic Drugs Advisory Committee,2010,2010-02-10,"POSTPONED: February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM199557.pdf,True,44KB
Oncologic Drugs Advisory Committee,2010,2010-02-10,"POSTPONED: February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the February 10, 2010 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224027/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm199558.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","December 17, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm191241.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192228.pdf,True,75KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm193929.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193934.pdf,True,65KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Committee Roster for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193935.pdf,True,63KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195679.pdf,True,73KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195680.pdf,True,48KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195681.pdf,True,52KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm195682.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197772.pdf,True,380KB
Oncologic Drugs Advisory Committee,2009,2009-12-17,"December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 17, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197997.pdf,True,68KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","December 16, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm191240.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Amendment to the December 16, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm192036.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192226.pdf,True,75KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm193916.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193925.pdf,True,62KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Committee Roster for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193927.pdf,True,60KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195673.pdf,True,72KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195716.pdf,True,368KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM195674.pdf,True,52KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm195675.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197771.pdf,True,356KB
Oncologic Drugs Advisory Committee,2009,2009-12-16,"December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 16, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197996.pdf,True,379KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","December 15, 2009: Pediatric Oncology Subcommittee Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm188032.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Materials for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm193907.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193842.pdf,True,68KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Questions for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193843.pdf,True,58KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Meeting Roster for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193844.pdf,True,76KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM193845.pdf,True,55KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM198002.pdf,True,56KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197908.pdf,True,50KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197909.pdf,True,75KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197911.pdf,True,589KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM197913.pdf,True,84KB
Oncologic Drugs Advisory Committee,2009,2009-12-15,"December 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the December 15, 2009 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm197914.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-06,"October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee - Meeting Cancelled","October 6, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm180085.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-06,"October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee - Meeting Cancelled","October 6, 2009: Amendment to the Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm182650.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-06,"October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee - Meeting Cancelled","Draft Agenda for the October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM182439.pdf,True,75KB
Oncologic Drugs Advisory Committee,2009,2009-10-06,"October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee - Meeting Cancelled","Waivers for Conflicts of Interest for the October 6, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm182902.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","October 5, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm180077.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM182438.pdf,True,87KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm182895.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183974.pdf,True,61KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183976.pdf,True,76KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM186331.pdf,True,59KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm183977.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM186327.pdf,True,80KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee-SCHERING",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM186328.pdf,True,43KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee-GSK",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM186330.pdf,True,43KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm186332.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM188370.pdf,True,78KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM191020.pdf,True,281KB
Oncologic Drugs Advisory Committee,2009,2009-10-05,"October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the October 5, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM191021.pdf,True,253KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","September 2, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm176523.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm177435.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180627.pdf,True,87KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180628.pdf,True,52KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180629.pdf,True,77KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm180630.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183037.pdf,True,147KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183276.pdf,True,294KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Errata to the Transcript for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM191022.pdf,True,37KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183277.pdf,True,315KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192179.pdf,True,84KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192180.pdf,True,49KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192181.pdf,True,83KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Roster for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192182.pdf,True,62KB
Oncologic Drugs Advisory Committee,2009,2009-09-02,"September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the September 2, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm192188.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","September 1, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm176525.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm177430.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180489.pdf,True,86KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180490.pdf,True,61KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM180491.pdf,True,77KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm180492.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183036.pdf,True,173KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183274.pdf,True,306KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM183275.pdf,True,268KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192160.pdf,True,82KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192162.pdf,True,121KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192164.pdf,True,50KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Roster for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM192165.pdf,True,60KB
Oncologic Drugs Advisory Committee,2009,2009-09-01,"September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the September 1, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm192166.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","July 15, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm164972.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm169657.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM174721.pdf,True,81KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM171167.pdf,True,253KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM171143.pdf,True,61KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM171144.pdf,True,62KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm171145.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the July 15, 2009 Meeting of the Oncologic Drug Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm176237.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM176247.pdf,True,43KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM176248.pdf,True,56KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM179291.pdf,True,92KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee - AM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM179894.pdf,True,476KB
Oncologic Drugs Advisory Committee,2009,2009-07-15,"July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the July 15, 2009 Meeting of the Oncologic Drugs Advisory Committee - PM Session",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM179895.pdf,True,1MB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","May 29, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm155163.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm151620.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM167287.pdf,True,72KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM155753.pdf,True,75KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM161237.pdf,True,50KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM161238.pdf,True,52KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committees",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm163889.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committees",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm179334.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM167291.pdf,True,108KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM170152.pdf,True,133KB
Oncologic Drugs Advisory Committee,2009,2009-05-29,"May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Transcript for the May 29, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM174726.pdf,True,452KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","March 31, 2009: Oncologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm136246.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm163884.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Agenda for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM148745.pdf,True,86KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Draft Agenda for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM148746.pdf,True,79KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Meeting Roster for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM148750.pdf,True,55KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Committee Roster for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM148756.pdf,True,52KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Meeting Roster for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM148757.pdf,True,71KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Briefing Information for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm148784.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Slides for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm148865.htm,False,
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Final Questions for the March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM148920.pdf,True,67KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Minutes for the March 31, 2009 Meeting of the Oncologic Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM148927.pdf,True,67KB
Oncologic Drugs Advisory Committee,2009,2009-03-31,"March 31, 2009 Meeting of the Oncologic Drugs Advisory Committee","Transcript for the March 31, 2009 Meeting of the Oncologic Advisory Committee",https://wayback.archive-it.org/7993/20170403224034/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM148933.pdf,True,324KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm490665.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM497061.pdf,True,24KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM497068.pdf,True,61KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm497062.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM500816.pdf,True,24KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM500817.pdf,True,60KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM500818.pdf,True,24KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm500819.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM509870.pdf,True,91KB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-04-25,"April 25, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the April 25, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM510390.pdf,True,1.2MB
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-01-22,"January 22, 2016 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","POSTPONED: January 22, 2016: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm478060.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2016,2016-01-22,"January 22, 2016 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the January 22, 2016 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224049/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm481907.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","November 24, 2015: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm467180.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473734.pdf,True,16KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm473736.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473735.pdf,True,68KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM475945.pdf,True,11KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM475946.pdf,True,18KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM475948.pdf,True,13KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm475950.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM480697.pdf,True,31KB
Peripheral and Central Nervous System Drugs Advisory Committee,2015,2015-11-24,"November 24, 2015 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the November 24, 2015 Meeting of the Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM485986.pdf,True,942KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","November 14, 2013: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371090.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374380.pdf,True,39KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374381.pdf,True,25KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374382.pdf,True,36KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374383.pdf,True,40KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm374384.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376691.pdf,True,28KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376693.pdf,True,14KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376704.pdf,True,32KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm376699.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM386060.pdf,True,44KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-14,"November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the November 14, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM386061.pdf,True,637KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","November 13, 2013: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm371089.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374179.pdf,True,35KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374180.pdf,True,29KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374181.pdf,True,113KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374182.pdf,True,35KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm374183.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376416.pdf,True,32KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376417.pdf,True,14KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM376418.pdf,True,64KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm376420.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM386058.pdf,True,50KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-11-13,"November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the November 13, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM386059.pdf,True,879KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","May 22, 2013: Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm346557.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM352963.pdf,True,248KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM352964.pdf,True,31KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM352965.pdf,True,130KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM352966.pdf,True,28KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm352968.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM352967.pdf,True,30KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM354210.pdf,True,21KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM354211.pdf,True,33KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM354212.pdf,True,53KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm354213.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM362213.pdf,True,56KB
Peripheral and Central Nervous System Drugs Advisory Committee,2013,2013-05-22,"May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the May 22, 2013 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224050/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM362214.pdf,True,825KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","May 24, 2012: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm298451.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM304823.pdf,True,36KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM304824.pdf,True,27KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM304825.pdf,True,43KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM304826.pdf,True,24KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM304827.pdf,True,30KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm304828.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM306112.pdf,True,23KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM306113.pdf,True,30KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM306114.pdf,True,69KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm306115.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM316335.pdf,True,42KB
Peripheral and Central Nervous System Drugs Advisory Committee,2012,2012-05-24,"May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the May 24, 2012 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224051/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM316336.pdf,True,2.1MB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","NEW START TIME: October 17, 2011: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm265704.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275468.pdf,True,33KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275469.pdf,True,25KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275470.pdf,True,83KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275471.pdf,True,27KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM275472.pdf,True,14KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm275473.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM277000.pdf,True,27KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM277002.pdf,True,16KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM277003.pdf,True,65KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm277004.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM284387.pdf,True,33KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-10-17,"October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the October 17, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM284388.pdf,True,642KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","March 10, 2011: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm240663.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Waivers for Conflicts of Interest for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm244278.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM246060.pdf,True,31KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM246062.pdf,True,26KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM246063.pdf,True,110KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM246064.pdf,True,22KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm246067.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM247484.pdf,True,21KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM247485.pdf,True,18KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM247486.pdf,True,25KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm247487.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM250489.pdf,True,41KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,2011-03-10,"March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the March 10, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM250490.pdf,True,736KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","January 20-21, 2011: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm235846.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240262.pdf,True,24KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240263.pdf,True,14KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240344.pdf,True,49KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240259.pdf,True,52KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240260.pdf,True,67KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm240264.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Webcast Information for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240349.pdf,True,14KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240350.pdf,True,39KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240351.pdf,True,23KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240352.pdf,True,21KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm240353.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240943.pdf,True,49KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240944.pdf,True,18KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM240946.pdf,True,33KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm240948.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM241067.pdf,True,19KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM241068.pdf,True,12KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM241069.pdf,True,70KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm241071.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM244441.pdf,True,111KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM244442.pdf,True,39KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM247947.pdf,True,709KB
Peripheral and Central Nervous System Drugs Advisory Committee,2011,,"January 20-21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the January 21, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224053/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM247948.pdf,True,323KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","November 3, 2010: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm225864.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231772.pdf,True,77KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231773.pdf,True,277KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM231774.pdf,True,58KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm231775.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM232203.pdf,True,98KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233351.pdf,True,73KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233404.pdf,True,71KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM233352.pdf,True,89KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm233353.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM243258.pdf,True,53KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-11-03,"November 3, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the November 3, 2010 Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM284384.pdf,True,560KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","August 11, 2010: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm217264.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM221677.pdf,True,50KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM221678.pdf,True,75KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM221679.pdf,True,93KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm221680.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM222572.pdf,True,53KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM222573.pdf,True,65KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM222574.pdf,True,72KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm222586.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM225324.pdf,True,80KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-08-11,"August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the August 11, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM225327.pdf,True,637KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","June 10, 2010: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm207667.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM214663.pdf,True,75KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM214664.pdf,True,85KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM214665.pdf,True,107KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Committee Roster for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM214666.pdf,True,69KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm214668.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM216532.pdf,True,49KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM216535.pdf,True,70KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM216539.pdf,True,86KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm216547.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM221183.pdf,True,93KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-06-10,"June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the June 10, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM221184.pdf,True,901KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","May 6, 2010: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm204893.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Waivers for Conflicts of Interest for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm209202.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM210483.pdf,True,75KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM210484.pdf,True,83KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Meeting Roster for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM210485.pdf,True,95KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM210486.pdf,True,69KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm210487.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM212944.pdf,True,65KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM212946.pdf,True,63KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM212949.pdf,True,66KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm212951.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM215394.pdf,True,99KB
Peripheral and Central Nervous System Drugs Advisory Committee,2010,2010-05-06,"May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the May 6, 2010 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM215396.pdf,True,594KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","October 14, 2009: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm180089.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM185658.pdf,True,81KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Meeting Roster for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM185659.pdf,True,104KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM185660.pdf,True,53KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm185661.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM185666.pdf,True,58KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191023.pdf,True,42KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191024.pdf,True,37KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191025.pdf,True,41KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191026.pdf,True,72KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm191027.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-10-14,"October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the October 14, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191028.pdf,True,696KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","August 11, 2009: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm165628.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM176187.pdf,True,61KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Committee Roster for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM176198.pdf,True,51KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Meeting Roster for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM176196.pdf,True,74KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM186391.pdf,True,25KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm176189.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM186388.pdf,True,54KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM176199.pdf,True,52KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM186390.pdf,True,42KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Minutes for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM183217.pdf,True,73KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm186395.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,2009-08-11,"August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM191398.pdf,True,477KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","January 7-8, 2009: Peripheral and Central Nervous System Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm153612.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Agenda for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153661.pdf,True,64KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Agenda for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153665.pdf,True,275KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Meeting Roster for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153727.pdf,True,59KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Members Roster for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153732.pdf,True,55KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Meeting Roster for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153746.pdf,True,88KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Briefing Information for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm153750.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Questions for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153786.pdf,True,60KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Draft Questions for the January 7 and 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153792.pdf,True,273KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the January 7, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm153794.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Slides for the January 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/ucm154399.htm,False,
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Minutes for the January 7, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM154791.pdf,True,113KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Final Minutes for the January 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM154779.pdf,True,101KB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the January 7, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM166105.pdf,True,7.5MB
Peripheral and Central Nervous System Drugs Advisory Committee,2009,,"January 7-8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee","Transcript for the January 8, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224054/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM166115.pdf,True,1023KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","March 15, 2017: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm535513.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology (PSCP) Advisory Committee",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm544832.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology (PSCP) Advisory Committee",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM546149.pdf,True,47KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology (PSCP) Advisory Committee",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM546150.pdf,True,25KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology (PSCP) Advisory Committee",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM546151.pdf,True,38KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2017,2017-03-15,"March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the March 15, 2017 Meeting of the Pharmaceutical Science and Clinical Pharmacology (PSCP) Advisory Committee",https://wayback.archive-it.org/7993/20170403224107/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM546152.pdf,True,26KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,2013-10-31,"October 31, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","CANCELLED October 31, 2013: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm369485.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,2013-10-30,"October 30, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","CANCELLED October 30, 2013: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm369467.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","September 25, 2013: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm361580.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm367941.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM369411.pdf,True,41KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM369412.pdf,True,20KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM369413.pdf,True,87KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM369414.pdf,True,29KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM370531.pdf,True,32KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM370532.pdf,True,14KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM370533.pdf,True,47KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm370534.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM380984.pdf,True,765KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2013,"Sept 25, 2013","Sept 25, 2013 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the September 25, 2013 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)",https://wayback.archive-it.org/7993/20170403224108/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM396502.pdf,True,54KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","August 9, 2012: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm312294.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm314579.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314578.pdf,True,31KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314580.pdf,True,30KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314581.pdf,True,30KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314583.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Notice for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314584.pdf,True,13KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm315766.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317064.pdf,True,26KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317067.pdf,True,25KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317068.pdf,True,18KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Recording for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317069.pdf,True,31KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM329505.pdf,True,59KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology - Topic 1",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM334485.pdf,True,414KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-09,"August 9, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 9, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology - Topic 2",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM334486.pdf,True,257KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","August 8, 2012: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm312874.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm314479.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314480.pdf,True,33KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314481.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314482.pdf,True,31KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314483.pdf,True,33KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Notice for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM314484.pdf,True,13KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm315760.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317040.pdf,True,24KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317041.pdf,True,21KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317042.pdf,True,21KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Recording for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM317044.pdf,True,30KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM329504.pdf,True,55KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology - Topic 1",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM334478.pdf,True,441KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-08-08,"August 8, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 8, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology - Topic 2",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM334481.pdf,True,205KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","March 14, 2012: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm286681.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Waivers for Conflicts of Interest for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm293569.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm295208.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM295550.pdf,True,36KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM295551.pdf,True,29KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM295552.pdf,True,66KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM295553.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM298460.pdf,True,24KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM298461.pdf,True,16KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM298462.pdf,True,37KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm298463.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM303015.pdf,True,441KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2012,2012-03-14,"March 14, 2012 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224110/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM306989.pdf,True,44KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","July 27, 2011: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm261310.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm263466.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM265141.pdf,True,46KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM265142.pdf,True,20KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM265143.pdf,True,51KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM265144.pdf,True,41KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Information for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM265146.pdf,True,16KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266745.pdf,True,26KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266746.pdf,True,11KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266747.pdf,True,32KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm266748.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Recording for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266749.pdf,True,14KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM272109.pdf,True,27KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-27,"July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the July 27, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM272110.pdf,True,715KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","July 26, 2011: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm261780.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm263464.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM264210.pdf,True,45KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM264211.pdf,True,21KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM264212.pdf,True,49KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM264213.pdf,True,41KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Information for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM264214.pdf,True,16KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the July 26, 2011 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266755.pdf,True,29KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the July 26, 2011 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266758.pdf,True,12KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the July 26, 2011 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266762.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the July 26, 2011 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm266768.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Webcast Recording for the July 26, 2011 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM266771.pdf,True,14KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM272111.pdf,True,22KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-07-26,"July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the July 26, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM272112.pdf,True,794KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","March 2, 2011: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm240582.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM244756.pdf,True,21KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM244757.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM244758.pdf,True,31KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Committee Roster for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM244759.pdf,True,29KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm244760.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm247633.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM251403.pdf,True,21KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM251404.pdf,True,28KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM251405.pdf,True,30KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM251406.pdf,True,47KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2011,2011-03-02,"March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the March 2, 2011 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224114/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM251407.pdf,True,664KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","April 14, 2010: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm204093.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm207736.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208126.pdf,True,92KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208127.pdf,True,75KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208128.pdf,True,95KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM209734.pdf,True,108KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM209735.pdf,True,81KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210795.pdf,True,78KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm209773.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM212047.pdf,True,36KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-14,"April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM212591.pdf,True,476KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","April 13, 2010: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm203405.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm207954.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208122.pdf,True,92KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208123.pdf,True,76KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM208125.pdf,True,103KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM209315.pdf,True,45KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM209316.pdf,True,82KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM209317.pdf,True,89KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm209318.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210930.pdf,True,107KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM212010.pdf,True,1011KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-04-13,"April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Errata to the Transcript for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM212589.pdf,True,59KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","March 17, 2010: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm201691.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm204260.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM204262.pdf,True,85KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Questions for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM204263.pdf,True,195KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Meeting Roster for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM204265.pdf,True,98KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210800.pdf,True,72KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210801.pdf,True,166KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210802.pdf,True,82KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm210804.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210803.pdf,True,773KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2010,2010-03-17,"March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the March 17, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224116/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM248402.pdf,True,597KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","August 5, 2009: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm170880.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm173744.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM174775.pdf,True,58KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Meeting Roster for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM174777.pdf,True,56KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm178925.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Questions for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm179009.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM179891.pdf,True,554KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-05,"August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the August 5, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM237492.pdf,True,67KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","August 4, 2009: Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm170157.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Briefing Information for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm172596.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Agenda for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM179393.pdf,True,54KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Draft Agenda for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM174672.pdf,True,43KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Meeting Roster for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM174674.pdf,True,49KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Committee Roster for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM179397.pdf,True,58KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Meeting Roster for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM179398.pdf,True,49KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Slides for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/ucm179399.htm,False,
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Final Questions for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM179396.pdf,True,40KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Transcript for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM183874.pdf,True,820KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Errata to the Transcript for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM183876.pdf,True,38KB
Pharmaceutical Science and Clinical Pharmacology Advisory Committee,2009,2009-08-04,"August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee","Minutes for the August 4, 2009 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee",https://wayback.archive-it.org/7993/20170403224117/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM237493.pdf,True,68KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","November 3, 2016: Meeting of the Pharmacy Compounding Advisory Committee Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm524130.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm524611.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Committee Roster for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM527425.pdf,True,25KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM527426.pdf,True,68KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM529461.pdf,True,34KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM529462.pdf,True,31KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM529463.pdf,True,18KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm529464.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Minutes for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM532434.pdf,True,47KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM536903.pdf,True,416KB
Pharmacy Compounding Advisory Committee,2016,2016-11-03,"November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM536905.pdf,True,366KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","June 23, 2016: Meeting of the Pharmacy Compounding Advisory Committee Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm504983.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm505040.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Committee Roster for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM507743.pdf,True,26KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM507744.pdf,True,68KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM509954.pdf,True,34KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM509955.pdf,True,13KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM509956.pdf,True,20KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm509957.htm,False,
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Minutes for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM516485.pdf,True,72KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM518584.pdf,True,330KB
Pharmacy Compounding Advisory Committee,2016,2016-06-23,"June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the June 23, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM518585.pdf,True,453KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","March 8-9, 2016: Pharmacy Compounding Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm486092.htm,False,
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm486144.htm,False,
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Committee Roster for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM489153.pdf,True,26KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM489154.pdf,True,69KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM490723.pdf,True,42KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM490724.pdf,True,24KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM490726.pdf,True,30KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm490727.htm,False,
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Minutes for the March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM500992.pdf,True,59KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the March 8, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM507771.pdf,True,448KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the March 8, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM507772.pdf,True,320KB
Pharmacy Compounding Advisory Committee,2016,,"March 8-9, 2016 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the March 9, 2016 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224125/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM507775.pdf,True,193KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","UPDATED TIME, AGENDA AND PUBLIC PARTICIPATION INFORMATION: October 27-28, 2015: Pharmacy Compounding Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm465374.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm465541.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Committee Roster for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM468787.pdf,True,17KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM468788.pdf,True,71KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM473829.pdf,True,40KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM473830.pdf,True,30KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM473831.pdf,True,35KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm473832.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the October 27, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM484905.pdf,True,324KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the October 27, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM484906.pdf,True,344KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the October 28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM484907.pdf,True,187KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the October 28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM484908.pdf,True,335KB
Pharmacy Compounding Advisory Committee,2015,,"October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Minutes for the October 27-28, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM500990.pdf,True,86KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","June 17-18, 2015: Pharmacy Compounding Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm449497.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm449533.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM451242.pdf,True,71KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM455271.pdf,True,38KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM455272.pdf,True,64KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM455273.pdf,True,45KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm455274.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the June 17, 2015 (AM Session) Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM458512.pdf,True,312KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the June 17, 2015 (PM Session) Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM458513.pdf,True,402KB
Pharmacy Compounding Advisory Committee,2015,,"June 17-18, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the June 18, 2015  Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM458514.pdf,True,328KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","February 23-24, 2015: Pharmacy Compounding Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm431283.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Briefing Information for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm433803.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Committee Roster for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM434864.pdf,True,45KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Webcast Information for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM434873.pdf,True,71KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the February 23, 2015 (AM Session) Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM444499.pdf,True,336KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the February 23, 2015 (PM Session) Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM444500.pdf,True,284KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Transcript for the February 24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM444501.pdf,True,392KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Agenda for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM445385.pdf,True,190KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Questions for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM445387.pdf,True,236KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Final Meeting Roster for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM445388.pdf,True,178KB
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Slides for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/ucm455114.htm,False,
Pharmacy Compounding Advisory Committee,2015,,"February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee","Minutes for the February 23-24, 2015 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)",https://wayback.archive-it.org/7993/20170403224128/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM500989.pdf,True,111KB
Psychopharmacologic Drugs Advisory Committee,2017,2017-02-16,"February 16, 2017 Meeting of the Psychopharmacologic Drugs Advisory Committee","CANCELLED February 16, 2017: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224136/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm535416.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","September 14, 2016: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm513811.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Psychopharmacologic Drugs Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520099.pdf,True,24KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520100.pdf,True,23KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm520102.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520101.pdf,True,69KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522575.pdf,True,26KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522576.pdf,True,13KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM522578.pdf,True,29KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm522580.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-09-14,"September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM524402.pdf,True,83KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","March 29, 2016: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm484121.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM492448.pdf,True,19KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm492451.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM492449.pdf,True,68KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM493990.pdf,True,21KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM493991.pdf,True,10KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM493992.pdf,True,24KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm493993.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM502046.pdf,True,30KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-03-29,"March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM502050.pdf,True,737KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","February 3, 2016: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm475312.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM484033.pdf,True,17KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm484035.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM484034.pdf,True,73KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Audio file for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM485058.pdf,True,33KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM485059.pdf,True,10KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM485060.pdf,True,10KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM485061.pdf,True,23KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm485062.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM491913.pdf,True,46KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Audio file for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/http://wayback.archive-it.org/7993/20170113060939/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM491097.mp3,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (AM Session)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM491914.pdf,True,451KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-02-03,"February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (PM Session)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM491915.pdf,True,417KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","January 12, 2016: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm476284.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM480909.pdf,True,18KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm480731.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM480730.pdf,True,67KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM482600.pdf,True,18KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM482601.pdf,True,30KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM482602.pdf,True,26KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm482604.htm,False,
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM500363.pdf,True,51KB
Psychopharmacologic Drugs Advisory Committee,2016,2016-01-12,"January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224137/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM500364.pdf,True,903KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","December 1, 2015: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm461697.htm,False,
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM474537.pdf,True,17KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm474539.htm,False,
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM474538.pdf,True,67KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM475730.pdf,True,24KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM475731.pdf,True,14KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM475732.pdf,True,25KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm475733.htm,False,
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM481253.pdf,True,39KB
Psychopharmacologic Drugs Advisory Committee,2015,2015-12-01,"December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the December 1, 2015 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)",https://wayback.archive-it.org/7993/20170403224141/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM481724.pdf,True,823KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","October 16, 2014: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and  the Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm394876.htm,False,
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Draft Agenda for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418698.pdf,True,404KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Draft Questions for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418699.pdf,True,386KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Draft Meeting Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418700.pdf,True,443KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Psychopharmacologic Drugs Advisory Committee Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418701.pdf,True,20KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Drug Safety and Risk Management Advisory Committee Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418702.pdf,True,24KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Briefing Information for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm418704.htm,False,
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Webcast Information for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM418703.pdf,True,69KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Final Agenda for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420252.pdf,True,27KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Final Questions for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420253.pdf,True,10KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Final Meeting Roster for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM420255.pdf,True,49KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Slides for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm420257.htm,False,
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Minutes for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM433774.pdf,True,38KB
Psychopharmacologic Drugs Advisory Committee,2014,2014-10-16,"October 16, 2014: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement","Transcript for the October 16, 2014 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224142/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM434007.pdf,True,761KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","March 21, 2013: Meeting of the Psychopharmacologic Drugs Advisory Committee  Meeting Announcement",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm341477.htm,False,
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Agenda for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM344367.pdf,True,253KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Questions for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM344368.pdf,True,251KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Meeting Roster for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM344369.pdf,True,250KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM344370.pdf,True,15KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm344372.htm,False,
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Webcast Information for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM344371.pdf,True,21KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM347234.pdf,True,16KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM347240.pdf,True,13KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM347242.pdf,True,13KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm347243.htm,False,
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM351452.pdf,True,860KB
Psychopharmacologic Drugs Advisory Committee,2013,2013-03-21,"March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the March 21, 2013 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224143/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM354333.pdf,True,28KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","December 12, 2011: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm277069.htm,False,
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Agenda for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM282890.pdf,True,36KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Questions for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM282892.pdf,True,22KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Meeting Roster for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM282893.pdf,True,91KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM282894.pdf,True,27KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm282895.htm,False,
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM283670.pdf,True,19KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM283672.pdf,True,16KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM283673.pdf,True,23KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm283674.htm,False,
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM288711.pdf,True,611KB
Psychopharmacologic Drugs Advisory Committee,2011,2011-12-12,"December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the December 12, 2011 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM288713.pdf,True,38KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","September 16, 2010: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm221386.htm,False,
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Agenda for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM225666.pdf,True,76KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Questions for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM225652.pdf,True,79KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Meeting Roster for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM225653.pdf,True,80KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm225654.htm,False,
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM232872.pdf,True,82KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM232753.pdf,True,72KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM232754.pdf,True,77KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM232755.pdf,True,97KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM232756.pdf,True,921KB
Psychopharmacologic Drugs Advisory Committee,2010,2010-09-16,"September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224145/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm232757.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","July 30, 2009: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm165554.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm173875.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM173880.pdf,True,53KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Meeting Roster for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM173881.pdf,True,65KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Agenda for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM173882.pdf,True,62KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Draft Questions for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM173883.pdf,True,49KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM179968.pdf,True,49KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM179969.pdf,True,53KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM179970.pdf,True,64KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM179971.pdf,True,41KB
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm179974.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,2009-07-30,"July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the July 30, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM179980.pdf,True,977KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","June 9-10, 2009: Psychopharmacologic Drugs Advisory Committee Meeting Announcement.",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm164160.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Waivers for Conflicts of Interest for the June 9, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm155504.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Agenda for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM164534.pdf,True,81KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Committee Roster for the June 9, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM164542.pdf,True,55KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Meeting Roster for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM164546.pdf,True,73KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Questions for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM164537.pdf,True,48KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the June 9, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm164276.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172846.pdf,True,96KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Meeting Roster for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172847.pdf,True,61KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172848.pdf,True,47KB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm172850.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the June 9, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172869.pdf,True,1.3MB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the June 10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172870.pdf,True,1.4MB
Psychopharmacologic Drugs Advisory Committee,2009,,"June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the June 9-10, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM197899.pdf,True,87KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","April 7-8, 2009: Psychopharmacologic Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm136250.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Posted Agenda for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161283.pdf,True,58KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Agenda for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161287.pdf,True,56KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Roster for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161289.pdf,True,75KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Roster for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161292.pdf,True,78KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm161294.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Briefing Information for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm161907.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Questions for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161971.pdf,True,41KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Questions for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM162440.pdf,True,93KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM161998.pdf,True,903KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Transcript for the April 8, 2009 Meeting Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM162005.pdf,True,759KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198209.pdf,True,52KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Agenda for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198210.pdf,True,48KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Roster for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198211.pdf,True,60KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Final Questions for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198212.pdf,True,47KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm198213.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Slides for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm198215.htm,False,
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the April 7, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198218.pdf,True,72KB
Psychopharmacologic Drugs Advisory Committee,2009,,"April 7-8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee","Minutes for the April 8, 2009 Meeting of the Psychopharmacologic Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224146/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM198219.pdf,True,72KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","December 10, 2015: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and the Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm469466.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Waiver for Conflicts of Interest for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm474207.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475972.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm475974.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Webcast Information for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475973.pdf,True,68KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477953.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477954.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477957.pdf,True,34KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm477958.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM482005.pdf,True,53KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-10,"December 10, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the December 10, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM487401.pdf,True,694KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","December 9, 2015: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm463629.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475756.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm475758.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Webcast Information for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM475757.pdf,True,68KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477879.pdf,True,23KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477880.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM477882.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm477883.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM482003.pdf,True,46KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-12-09,"December 9, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the December 9, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM487402.pdf,True,775KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","June 11, 2015: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm446464.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM450242.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm450243.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM452850.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM452851.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM452852.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm452853.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM459228.pdf,True,649KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-06-11,"June 11, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the June 11, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM462804.pdf,True,31KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","May 12, 2015: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm440783.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM446191.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm446192.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM447287.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM447288.pdf,True,11KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM447289.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm447290.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM451555.pdf,True,44KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-05-12,"May 12, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the May 12, 2015 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM455654.pdf,True,650KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","March 19, 2015: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm433812.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Pulmonary-Allergy Drugs Advisory Committee Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM438376.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Drug Safety and Risk Management Advisory Committee Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM438377.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm438378.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440057.pdf,True,28KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440058.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM440059.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm440061.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM443421.pdf,True,52KB
Pulmonary-Allergy Drugs Advisory Committee,2015,2015-03-19,"March 19, 2015 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the March 19, 2015 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSaRM)",https://wayback.archive-it.org/7993/20170403224158/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM447787.pdf,True,866KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","October 21, 2014: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm417332.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Agenda for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM419185.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Questions for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM419186.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Meeting Roster for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM419187.pdf,True,36KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM419188.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm419190.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Webcast Information for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM419189.pdf,True,67KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM420666.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM420667.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM420668.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm420669.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM422838.pdf,True,33KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-10-21,"October 21, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the October 21, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM433343.pdf,True,748KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","August 14, 2014: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm403018.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Agenda for the August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM409192.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Questions for the August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM409193.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Meeting Roster for the August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM409194.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Committee Roster for the August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM409195.pdf,True,35KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm409197.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Webcast Information for the August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM409196.pdf,True,67KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM410974.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM410975.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM410976.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm410977.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM416246.pdf,True,32KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-08-14,"August 14, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the August 14, 2014 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM416247.pdf,True,516KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","February 25, 2014: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm380886.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Agenda for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386668.pdf,True,41KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Questions for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386669.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Draft Meeting Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386670.pdf,True,74KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Pulmonary-Allergy Drugs Advisory Committee Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386672.pdf,True,32KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Nonprescription Drugs Advisory Committee Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386671.pdf,True,32KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Briefing Information for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm386673.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Webcast Information for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM386674.pdf,True,68KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Agenda for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388044.pdf,True,29KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Questions for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388045.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Final Meeting Roster for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM388047.pdf,True,154KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Slides for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm388048.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Minutes for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM395525.pdf,True,62KB
Pulmonary-Allergy Drugs Advisory Committee,2014,2014-02-25,"February 25, 2014 Meeting of the Pulmonary Allergy Drugs Advisory Committee","Transcript for the February 25, 2014 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224202/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/UCM400231.pdf,True,778KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","September 10, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm363597.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM367404.pdf,True,52KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM367405.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM367406.pdf,True,40KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM367407.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm367409.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM367408.pdf,True,17KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM368629.pdf,True,43KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM368630.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM368631.pdf,True,28KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm368633.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM370819.pdf,True,659KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-09-10,"September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the September 10, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM374390.pdf,True,41KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","April 17, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm344930.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347924.pdf,True,45KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347925.pdf,True,23KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM348331.pdf,True,45KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347926.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm347928.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347927.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM348802.pdf,True,41KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM348803.pdf,True,16KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM348804.pdf,True,16KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm348805.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM350491.pdf,True,35KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-04-17,"April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the April 17, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM363839.pdf,True,559KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-03-07,"March 7, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","POSTPONED DUE TO WEATHER: March 7, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm332202.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","January 30, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm329188.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336990.pdf,True,45KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM337132.pdf,True,17KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336991.pdf,True,40KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336992.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm336994.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336993.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM338456.pdf,True,41KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM338458.pdf,True,13KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM338460.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm338461.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM340156.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-30,"January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the January 30, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM344679.pdf,True,1.7MB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","January 29, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm329179.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336755.pdf,True,45KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336756.pdf,True,21KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336904.pdf,True,43KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336757.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm336759.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM336758.pdf,True,14KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM337981.pdf,True,39KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM337982.pdf,True,10KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM337984.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm337985.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM343561.pdf,True,1.6MB
Pulmonary-Allergy Drugs Advisory Committee,2013,2013-01-29,"January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the January 29, 2013 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224205/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347286.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","February 23, 2012: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm289559.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM292613.pdf,True,28KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM292615.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM292616.pdf,True,37KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM292617.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM292618.pdf,True,29KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm292619.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM293986.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM293988.pdf,True,12KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM293991.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm293994.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM299315.pdf,True,34KB
Pulmonary-Allergy Drugs Advisory Committee,2012,2012-02-23,"February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the February 23, 2012 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224208/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM299317.pdf,True,1.6MB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","June 23, 2011: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm256401.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM260014.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM260016.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM260017.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM260192.pdf,True,30KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm260019.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM262466.pdf,True,16KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM262468.pdf,True,12KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM262469.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm262470.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM266638.pdf,True,42KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-06-23,"June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the June 23, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM266639.pdf,True,643KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","March 8, 2011:  Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm238266.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM245525.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM245531.pdf,True,23KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM245532.pdf,True,36KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Committee Roster for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM245533.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Webcast Information for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM245633.pdf,True,15KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm245635.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM247177.pdf,True,18KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM247180.pdf,True,15KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM247181.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm247182.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM248744.pdf,True,47KB
Pulmonary-Allergy Drugs Advisory Committee,2011,2011-03-08,"March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the March 8, 2011 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224209/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM250243.pdf,True,692KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","April 7, 2010: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm202852.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm207376.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM207217.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM207219.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM207221.pdf,True,38KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM208705.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM208706.pdf,True,13KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM208707.pdf,True,24KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm208708.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM212109.pdf,True,103KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-04-07,"April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the April 7, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM212606.pdf,True,838KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","March 10-11, 2010: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm199871.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203166.pdf,True,77KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203167.pdf,True,277KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203168.pdf,True,93KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm202692.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206716.pdf,True,77KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206718.pdf,True,68KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206719.pdf,True,82KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm206720.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the March 10-11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM209117.pdf,True,221KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the March 10, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM209122.pdf,True,656KB
Pulmonary-Allergy Drugs Advisory Committee,2010,,"March 10-11, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the March 11, 2010 Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM209124.pdf,True,522KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","March 9, 2010: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm200307.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203074.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203075.pdf,True,218KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203076.pdf,True,31KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm203079.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206376.pdf,True,16KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206377.pdf,True,13KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Meeting Roster for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM206378.pdf,True,23KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm206382.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM208805.pdf,True,97KB
Pulmonary-Allergy Drugs Advisory Committee,2010,2010-03-09,"March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224211/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM208806.pdf,True,775KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","November 20, 2009: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm183948.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190747.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190748.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Roster for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190749.pdf,True,36KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm190750.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194150.pdf,True,16KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194151.pdf,True,26KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Roster for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194152.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm194154.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM199394.pdf,True,41KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-20,"November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the November 20, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM198007.pdf,True,1.3MB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","November 19, 2009: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm183398.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190457.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190458.pdf,True,21KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Roster for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190460.pdf,True,34KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm190461.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194078.pdf,True,15KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194079.pdf,True,28KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Roster for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194080.pdf,True,19KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm194081.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM196995.pdf,True,39KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-19,"November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the November 19, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM198006.pdf,True,1MB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","November 18, 2009: Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm183968.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190432.pdf,True,20KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190433.pdf,True,21KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Roster for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190436.pdf,True,36KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm190447.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Agenda for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194048.pdf,True,22KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Questions for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194049.pdf,True,27KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Final Roster for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM194050.pdf,True,23KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm194063.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM199392.pdf,True,46KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-11-18,"November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the November 18, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM198005.pdf,True,530KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","February 4, 2009: Pulmonary-Allergy Drug Advisory Committee Meeting Announcement",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/Calendar/ucm170230.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Agenda for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM170321.pdf,True,31KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Meeting Roster for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM170323.pdf,True,59KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Briefing Information for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm170326.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Draft Questions for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM170343.pdf,True,25KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Slides for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ucm170346.htm,False,
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Minutes for the February 04, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM170344.pdf,True,48KB
Pulmonary-Allergy Drugs Advisory Committee,2009,2009-02-04,"February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee","Transcript for the February 4, 2009 Meeting of the Pulmonary-Allergy Drugs Advisory Committee",https://wayback.archive-it.org/7993/20170403224214/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM188185.pdf,True,409KB
